EurekaMag PDF full texts Chapter 32,166

Pistritto, G.; Pozzoli, G.; Mancuso, C.; Tringali, G.; Preziosi, P.; Navarra, P. 1997: Lipopolysaccharide stimulates COX activities in rat hypothalamic astrocytes via the activation of multiple pathways. Society for Neuroscience Abstracts 23(1-2): 994

Leclercq, G.; Plum, J. 1995: Lipopolysaccharide stimulates T cell receptor V-gamma-3 cells. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 250

Taffet, S.M.; Brown, M.C.; Zheng, S. 1993: Lipopolysaccharide stimulates both nuclear localization of the NF-kappa-B 50 kDa subunit and processing of the 105 kDa precursor in macrophage-like cells. Journal of Immunology 150(8 Part 2): 84A

Savard, C.E.; Blinman, T.A.; Pandol, S.J.; Lee, S.P. 1998: Lipopolysaccharide stimulates cytokine production by mouse gallbladder epithelial cells. Gastroenterology 114(4 Part 2): A1077

Li, Q.; FalklerW.Jr.; Bever, C.Jr 1993: Lipopolysaccharide stimulates intracellular cathepsin B activity in THP-1 cells. Abstracts of the General Meeting of the American Society for Microbiology 93: 93

Cha, J.H.; Teng Umnuay, P.; Zhang, L.; Madsen, K.M. 1996: Lipopolysaccharide stimulates osteopontin mRNA and protein expression in mouse distal tubule. Journal of the American Society of Nephrology 7(9): 1694

Forhand, J.R.; Johnston, R.B.Jr; Bomalaski, J.S. 1990: Lipopolysaccharide stimulates phospholipase a2 activity in human neutrophils possible involvement in priming for an enhanced respiratory burst. Clinical Research 38(2): 434A

Forehand, J.R.; Johnston, R.B.Jr; Bomalaski, J.S. 1990: Lipopolysaccharide stimulates phospholipase a2 activity in human neutrophils possible role of phospholipase a2 in priming for an enhanced respiratory burst. Arthritis and Rheumatism 33(9 Suppl): S109

Iwasaki, Y.; Taguchi, T.; Nishiyama, M.; Asai, M.; Yoshida, M.; Kambayashi, M.; Takao, T.; Hashimoto, K. 2008: Lipopolysaccharide stimulates proopiomelanocortin gene expression in AtT20 corticotroph cells. Endocrine Journal 55(2): 285-290

Sisson, J.; Jain, B.; Robbins, R.A. 1995: Lipopolysaccharide stimulates rapid and delayed nitric oxide-dependent increases in airway epithelial ciliary motility. Journal of Investigative Medicine 43(Suppl 3): 471A

Francis, J.; Moham Kumar, P.S.; Mohankumar, S.M.J.; Quadri, S.K. 1998: Lipopolysaccharide stimulates the release of norepinephrine from the hypothalamus in-vitro. Society for Neuroscience Abstracts 24(1-2): 2075

Fox, E.S.; Hafenrichter, D.G.; Flye, M.W. 1994: Lipopolysaccharide stimulation of isolated Kupffer cells is a CD14 independent process. Hepatology 20(4 Part 2): 209A

Funk, J.L.; Feingold, K.R.; Grunfeld, C. 1992: Lipopolysaccharide stimulation of macrophages induces foam cell formation. Clinical Research 40(2): 311A

Bach, R.R.; Moldow, C.F. 1993: Lipopolysaccharide stimulation of mononuculear cell tissue factor synthesis in human blood is enhanced by staurosporine. Blood 82(10 Suppl 1): 272A

Hampton, R.Y.; Golenbock, D.T.; Raetz, C.R.H. 1990: Lipopolysaccharide stimulation regulates lipid a metabolism in macrophage cell lines. FASEB Journal 4(7): A1908

Pinkart, H.C.; White, D.C. 1995: Lipopolysaccharide structure of solvent-tolerant Pseudomonas putida Idaho. Abstracts of the General Meeting of the American Society for Microbiology 95: 543

Sultzer, B.; Bandekar, J.; Castagna, R.; Abu Lawi, K. 1991: Lipopolysaccharide suppression of lymphocyte and macrophage function. FASEB Journal 5(6): A1706

Victorov, A.V.; Gladkaya, E.M.; Novikov, D.K.; Kosykh, V.A.; Yurkiv, V.A. 1989: Lipopolysaccharide toxin can directly stimulate the intracellular accumulation of lipids and their secretion into medium in the primary culture of rabbit hepatocytes. Febs Letters 256(1-2): 155-158

Brandes, R.P.; Graeper, S.; Busse, R.; Muegge, A.; Muelsch, A. 1998: Lipopolysaccharide treatment induces nitrate tolerance and down-regulates the soluble guanylyl cyclase in rat aorta. Circulation 98(17): I111-I112

Brandes, R.P.; Koddenberg, G.; Muelsch, A.; Muegge, A. 1998: Lipopolysaccharide treatment induces nitrate tolerance and down-regulates the soluble guanylyl cyclase in the rat aorta. European Heart Journal 19(ABST Suppl ): 579

Boutelle, S.L.P.; Peters, T.S.; Shaffer, R.A.; Lewis, S.J. 1993: Lipopolysaccharide treatment may reduce the activity of constitutive nitric oxide synthase within pre-ganglionic sympathetic terminals. Circulation 88(4 Part 2): I355

Wizemann, T.M.; Laskin, D.L. 1993: Lipopolysaccharide treatment of rats alters oxidative metabolism in pulmonary interstitial and alveolar macrophages. Abstracts of the General Meeting of the American Society for Microbiology 93: 145

Kichian, K.; Nestel, F.P.; Ponka, P.; Lapp, W.S. 1995: Lipopolysaccharide triggered interleukin-12 mediates interferon-gamma production during acute graft-versus-host disease. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 431

Dagenais, P.; Thivierge, M.; Parent, J.L.; Stankova, J.; Rola Pleszczynski, M. 1996: Lipopolysaccharide up-regulates platelet-activating factor receptor gene expression via tumor necrosis factor-alpha in human monocytes. FASEB Journal 10(3): A258

Carr, D.P.; Pearson, J.D. 1990: Lipopolysaccharide upregulates endothelial cell ec tissue factor tf by a protein kinase c pkc independent mechanism. British Journal of Haematology 76(Suppl 1): 14

Regueiro, M.D.; Wershil, B.K. 1997: Lipopolysaccharide upregulates the expression of stem cell factor mRNA in human colonic epithelial and intestinal fibroblast cell lines. Gastroenterology 112(4 Suppl): A1068

Mayoral, J.L.; Cody, C.S.; Burd, R.S.; Sawyer, M.D.; Raymond, C.S.; Dunn, D.L. 1991: Lipopolysaccharide uptake by macrophages is enhanced by anti lipopolysaccharide monoclonal antibodies. Surgical Forum 42: 110-112

Leon, L.R.; Kozak, W.; Peschon, J.; Kluger, M.J. 1996: Lipopolysaccharide, but not turpentine induces exacerbated fevers in TNF double receptor knockout mice. Society for Neuroscience Abstracts 22(1-3): 1456

Alving, C.R. 1993: Lipopolysaccharide, lipid A, and liposomes containing lipid a as immunologic adjuvants. Immunobiology 187(3-5): 430-446

Kitajima, S.; Tsuda, M.; Eshita, N.; Mitsushima, Y.; Saito, M.; Momma, J.; Kurokawa, Y. 1995: Lipopolysaccharide-associated increase in serum and urinary nitrite/nitrate levels and hematological changes in rats. Journal of Toxicological Sciences 20(4): 510

Hoover, Gordon J.; Simko, Elemir; El Mowafi, Adel; Ferguson, Hugh G.; Hayes, M. Anthony 1998: Lipopolysaccharide-binding lectins and pentraxins in plasma of salmonids genetically resistant to Aeromonas salmonicida. FASEB Journal 12(5): A807

Tobias, P.S.; Ulevitch, R.J. 1994: Lipopolysaccharide-binding protein and CD14 in the lipopolysaccharide-dependent activation of cells. Chest 105(3 Suppl): 48s-50s

Goldblum, S.E.; Brann, T.W.; Ding, X.; Pugin, J.; Tobias, P.S. 1993: Lipopolysaccharide-binding protein and soluble CD14 are accessory molecules for lipopolysaccharide-induced changes in endothelial barrier function. Clinical Research 41(2): 281A

Gegner, J.A.; Tobias, P.S. 1998: Lipopolysaccharide-binding proteins and receptors. Robinson, J P, Babcock, G F Cytometric Cellular Analysis Series; Phagocyte function: A guide for research and clinical evaluation 125-154

Ivanova, E.; Toshkova, R. 1993: Lipopolysaccharide-containing cytoplasmic membranes as stimulators of the polymorphonuclear function in hamsters with a transplantable Graffi tumour. Comptes Rendus de l'Academie Bulgare des Sciences 45(12): 129-132

Dohgu, S.; Banks, W.A. 2008: Lipopolysaccharide-enhanced transcellular transport of HIV-1 across the blood-brain barrier is mediated by the p38 mitogen-activated protein kinase pathway. Experimental Neurology 210(2): 740-749

Arditi, M.; Zhou, J.; Durden, D.; Torres, M.; Kim, K.S. 1994: Lipopolysaccharide-induced IL-6 production in vascular endothelial cells Role of tyrosine phosphorylation in transmembrane signaling. FASEB Journal 8(4-5): A1019

Laine, V.J.O.; Nyman, K.; Peuravuori, H.J.; Nevalainen, T.J. 1994: Lipopolysaccharide-induced apoptosis of rat pancreatic acinar cells. Digestion 55(5): 310

Fernández, R.; González, S.; Rey, S.; Cortés, P.P.; Maisey, K.R.; Reyes, E.-P.; Larraín, C.; Zapata, P. 2008: Lipopolysaccharide-induced carotid body inflammation in cats: functional manifestations, histopathology and involvement of tumour necrosis factor-alpha. Experimental Physiology 93(7): 892-907

Brian, J.E.Jr; Heistad, D.D.; Faraci, F.M. 1994: Lipopolysaccharide-induced cerebral arteriolar dilatation. FASEB Journal 8(4-5): A29

Heine, H.; Ulmer, A.J.; Flad, H.D.; Hauschild, S. 1994: Lipopolysaccharide-induced change of phosphorylation of cytosolic proteins in human monocytes. Immunobiology 191(2-3): 126-127

Reverte, M.; Diez Panero, L.M.; Eleno, N.; Lopez Novoa, J.M. 1996: Lipopolysaccharide-induced changes in nitric oxide production in rat glomeruli. Fundamental and Clinical Pharmacology 10(1): 74

Beaty, C.D.; Franklin, T.L.; Uehara, Y.; Wilson, C.B. 1994: Lipopolysaccharide-induced cytokine production in human monocytes: role of tyrosine phosphorylation in transmembrane signal transduction. European Journal of Immunology 24(6): 1278-1284

May, P.C.; Robison, P.M.; Berry, R.; Waters, D.; Gitter, B. 1992: Lipopolysaccharide-induced cytotoxicity in primary rat hippocampal cultures. Society for Neuroscience Abstracts 18(1-2): 166

Oladehin, A.; Blatteis, C.M. 1995: Lipopolysaccharide-induced fos expression in the hypothalamic preoptic area and paraventricular nucleus of neonatal rats. FASEB Journal 9(3): A377

Sewerynek, E.; Reiter, R.J.; Ortiz, G.G.; Pablos, M.; Melchiorri, D.; Lewinski, A. 1996: Lipopolysaccharide-induced genotoxicity is reduced by melatonin in vivo. Journal of Endocrinology 148(Suppl ): P3

Tonchev, A.; Valchanov, K.; Pancheva, R.; Chaldakov, G.N. 1997: Lipopolysaccharide-induced mast cell proliferation in the skin of the rat Prevention by pentoxifylline. Annals of Anatomy 179(2): 196

Kawanishi, N.; Tanaka, Y.; Kato, Y.; Shiva, D.; Yano, H. 2008: Lipopolysaccharide-induced monocyte chemotactic protein-1 is enhanced by suppression of nitric oxide production, which depends on poor CD14 expression on the surface of skeletal muscle. Cell Biochemistry and Function 26(4): 486-492

Doherty, D.E.; Worthen, G.S. 1994: Lipopolysaccharide-induced monocyte retention in the lungs of rabbits. Role of cell stiffness and the CD11/CD18 leukocyte adhesion complex. Chest 105(3 Suppl): 108s

Takada, H.; Ishimura, M.; Inada, H.; Ohga, S.; Kusuhara, K.; Moroi, Y.; Furue, M.; Hara, T. 2008: Lipopolysaccharide-induced monocytic cell death for the diagnosis of mild neonatal-onset multisystem inflammatory disease. Journal of Pediatrics 152(6): 885

Ha, T.; Hua, F.; Liu, X.; Ma, J.; McMullen, J.R.; Shioi, T.; Izumo, S.; Kelley, J.; Gao, X.; Browder, W.; Williams, D.L.; Kao, R.L.; Li, C. 2008: Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism. Cardiovascular Research 78(3): 546-553

Mohankumar, S.M.J.; Mohankumar, P.S.; Quadri, S.K. 1995: Lipopolysaccharide-induced neurotransmitter changes in the brain Blockade by IL-1 receptor antagonist. FASEB Journal 9(4): A920

Yamashita, M.; Yamaki, K.; Ohuchi, K. 1997: Lipopolysaccharide-induced nitric oxide production in RAW 2647 cells, and its inhibition by auranofin. Japanese Journal of Pharmacology 75(Suppl 1): 88P

Paintlia, M.K.; Paintlia, A.S.; Contreras, M.A.; Singh, I.; Singh, A.K. 2008: Lipopolysaccharide-induced peroxisomal dysfunction exacerbates cerebral white matter injury: attenuation by N-acetyl cysteine. Experimental Neurology 210(2): 560-576

Lucas, K.A.; Flynn, J.T. 1996: Lipopolysaccharide-induced production of PGE-2 by human microvascular endothelial cells is attenuated by tyrosine kinase and protein kinase C inhibitors. FASEB Journal 10(3): A576

Jeohn, G.H.; Kong, L.Y.; Hong, J.S. 1996: Lipopolysaccharide-induced proinflammatory cytokine mRNA expression in mixed glia cultures Suppression by protein tyrosine kinase inhibitors. Society for Neuroscience Abstracts 22(1-3): 1355

Webel, D.M.; Johnson, R.W.; Baker, D.H. 1998: Lipopolysaccharide-induced reductions in food intake do not decrease the efficiency with which lysine and threonine are utilized for protein accretion in chickens. Journal of Dairy Science 81(Suppl 1): 189

Vonhof, S.; Brost, B.; Stille Siegener, M.; Grumbach, I.M.; Fuchs, J.B.; Kreuzer, H.; Figulla, H.R. 1995: Lipopolysaccharide-induced tumour necrosis factor-alpha and interleukin-1 factor-alpha release in patients with idiopathic dilated cardiomyopathy and coronary artery disease. European Heart Journal 16(ABSTR Suppl ): 359

Ray, A.; Ray, B.K. 1995: Lipopolysaccharide-induction of serum amyloid a gene expression in rabbit liver. FASEB Journal 9(6): A1419

Espinoza, A.M.; Koles, N.L.; Hines, A.; Guelde, G.; Pollack, M. 1994: Lipopolysaccharide-specific monoclonal antibodies regulate lipopolysaccharide binding to human monocytes in vitro. Clinical Research 42(2): 152A

Aldridge, C.; Razzak, A.; Babcock, T.A.; Helton, W.S.; Espat, N.J. 2008: Lipopolysaccharide-stimulated RAW 264.7 macrophage inducible nitric oxide synthase and nitric oxide production is decreased by an omega-3 fatty acid lipid emulsion. Journal of Surgical Research 149(2): 296-302

Goodman, R.B.; Martin, T.R. 1994: Lipopolysaccharide-stimulated human alveolar macrophages produce mRNA for a spectrum of a-chemokines. Chest 105(3 Suppl): 99s

Kimbro, K.S.; Gebhardt, M.; Saavedra, R.A. 1994: Lipopolysaccharides and dexamethasone induce changes in interactions between DNA-binding proteins and DNA regulatory motifs of the osteopontin gene in osteosarcoma cells. Proceedings of the American Association for Cancer Research Annual Meeting 35: 559

Axelsson, L.G.; Landstroem, E.; Bylund Fellenius, A.C. 1995: Lipopolysaccharides are not essential for the mortality seen in DSS induced colitis. Gastroenterology 108(4 Suppl): A775

Tamura, M.; Howard, E.F.; Landon, E.J.; Tanner, M.; Myers, P.R. 1998: Lipopolysaccharides downregulate angiotensin II type 2 receptor in rat cardiac fibroblasts. FASEB Journal 12(5): A1005

Monteiro, M.A.; Moran, A.P.; Lee, A.; Perry, M.B. 1997: Lipopolysaccharides from Helicobacter mustelae and Helicobacter felis type strains. Gut 41(Suppl 1): A117

Aspinall, G.O.; Monteiro, M.A.; Moran, A.P.; Pang, H.; Penner, J.L.; Shaver, R.T. 1995: Lipopolysaccharides from Helicobacter pylori. Progress in Clinical and Biological Research 392: 93-101

Araki, Y. 1993: Lipopolysaccharides from pathogenic bacteria against fish. Radioisotopes 42(3): 203-204

Kim, S.J.; Kato, T.; Naito, Y.; Hirai, K.; Choi, J.I.; Takazoe, I.; Okuda, K. 1994: Lipopolysaccharides from various Capnocytophaga strains possess potent Limulus amoebocyte lysate clotting activity. Bulletin of Tokyo Dental College 35(1): 17-21

Briner, V.A.; Von Gruenigen, C. 1993: Lipopolysaccharides induce bovine glomerular endothelial cell injury and stimulated glomerular mesangial cell contraction in vitro. Journal of the American Society of Nephrology 4(3): 545

Xing, Z.; Ohtoshi, T.; Jordana, M.; Gauldie, J. 1992: Lipopolysaccharides induce gm csf il 8 and il 6 gene expression in human nasal fibroblasts but not in lung fibroblasts. American Review of Respiratory Disease 145(4 Part 2): A637

Koga, T.; Kimura, S.; Hamada, S. 1998: Lipopolysaccharides induce murine B lymphocyte activation through tyrosine and threonine phosphorylation pathways. Abstracts of the General Meeting of the American Society for Microbiology 98: 124

Hamada, S.; Takada, H.; Ogawa, T.; Fujiwara, T.; Mihara, J. 1990: Lipopolysaccharides of oral anaerobes associated with chronic inflammation: chemical and immunomodulating properties. International Reviews of Immunology 6(4): 247-261

Takada, H.; Iki, K.; Sakuta, T.; Sugiyama, A.; Sawamura, S.; Hamada, S. 1995: Lipopolysaccharides of oral black pigmented bacteria and periodontal diseases. a novel immunomodulator different from endotoxin was extracted from Prevotella intermedia ATCC 25611 with hot phenol-water. Progress in Clinical and Biological Research 392: 59-68

Zych, K.; Sidorczyk, Z. 1989: Lipopolysaccharides of proteus penneri new species. Carbohydrate Research 188: 105-112

Zherebilo, O.E.; Gvozdyak, R.I.; Moros, S.N.; Tarnavskaya, N.M. 1994: Lipopolysaccharides of typical pectobacteria of genus Erwinia. Lemattre, M, Freigoun, S, Rudolph, K, Swings, J G, INRA Colloquia; Plant pathogenic bacteria, Colloques de l'INRA; Plant pathogenic bacteria 241-246

Aspinall, G.O.; Mcdonald, A.G.; Raju, T.S. 1991: Lipopolysaccharides provide a molecular basis for serotyping campylobacter jejuni. Abstracts of Papers American Chemical Society 201(1-2): CARB 5

Olsson, L.E.; Wheeler, M.A.; Smith, S.D.; Weiss, R.M. 1998: Lipopolysaccharides upregulate cytokines and inducible nitric oxide synthase in rat urinary bladder. Journal of Urology 159(5 Suppl): 310

Golding, B. 1998: Lipopplysaccharide conjugate vaccines. Official Gazette of the United States Patent and Trademark Office Patents 1215(3): 2927

Mizushima, Y. 1991: Lipo-prostaglandin preparations. Prostaglandins Leukotrienes and Essential Fatty Acids 42(1): 1-6

Santos, R.; Borba, E.; Vinagre, C.; Bonfa, E.; Cossermelli, W.; Bellotti, G.; Pileggi, F.; Maranhao, R. 1996: Lipoprotein , anticardiolipin antibodies and triglyceride levels in systemic lupus erythematosus. European Heart Journal 17(ABSTR Suppl ): 331

Schaefer, E.J.; Ordovas, J.M.; Deluca, C.; Dagostino, R.B.; Wolf, P.A.; Taddei Peters, W.; Butman, R.J.; Silberman, S.R.; Wilson, P.W.F. 1997: Lipoprotein , coronary heart disease, and carotid artery atherosclerosis in the Framingham Heart Study. Clinical Chemistry 43(6 Part 2): S267

Gazzaruso, C.; Villa, R.F.; Priori, F.; Falcone, C.; Geroldi, D.; Fratino, P. 1993: Lipoprotein , inhibitor-1 of plasminogen activator and triglycerides in ischemic cardiopathy. Giornale Italiano di Chimica Clinica 17(4): 239-242, 1992

Ariyo, A.A.; Ridker, P.M.; Stampfer, M.J.; Hennekens, C.H. 1997: Lipoprotein , lipids, aspirin and risk of myocardial infarction in the Physicians Health Study. Journal of the American College of Cardiology 29(2 Suppl A): 76A

Earle, K.A.; Morocutti, A.; Mattock, M.; Piras, G.; Arvanitis, D.; Viberti, G.C. 1993: Lipoprotein , renal function and cardiovascular disease in type 1 diabetic patients. Diabetologia 36(Suppl 1): A205

Haider, A.W.; Davies, G.J. 1998: Lipoprotein , stability of coronary reperfusion and efficacy of thrombolytic therapy. Journal of the American College of Cardiology 31(2 Suppl A): 195A

Ullrich, H.; Lackner, K.; Schmitz, G. 1997: Lipoprotein -apheresis in the secondary prevention of coronary heart disease. Transfusion Science 17(4): 511-517

Skiba, P.; Keesler, G.A.; Li, Y.; Tabas, I. 1993: Lipoprotein /apoprotein receptor activity on macrophage foam cells is down-regulated by interferon-gamma. Circulation 88(4 Part 2): I272

Petri, M.; Miller, J.; Ebert, R.F.; Goldman, D. 1995: Lipoprotein A is predictive of myocardial infarction in SLE. Arthritis and Rheumatism 38(9 Suppl): S220

Bernardini, S.; Cortese, C.; Motti, C.; Federici, G. 1995: Lipoprotein A new marker of the atherosclerotic risk. Giornale Italiano di Chimica Clinica 20(2): 131-138

Lasser, D.; Baxi, L. 1996: Lipoprotein A serum levels are significantly elevated in preeclampsia. American Journal of Obstetrics and Gynecology 174(1 Part 2): 453

Parameshwar, J.; Foote, J.; Sharples, L.; Wallwork, J.; Large, S.; Schofield, P. 1994: Lipoprotein A, lipids and coronary artery disease after cardiac transplantation. Journal of Heart and Lung Transplantation 13(1 Part 2): S59

Ongajyooth, L.; Sirisalee, K.; Laohaphand, T.; Parichatiganond, P.; Shayakul, C.; Nilwarangkur, S. 1993: Lipoprotein abnormalities in adult nephrotic syndrome. Journal of the Medical Association of Thailand 76(9): 512-520

Duchene, M.; Von, S., U.; Domdey, H. 1996: Lipoprotein I of pseudomonas aeruginosa. Official Gazette of the United States Patent and Trademark Office Patents 1189(4): 2895-2896

Cantin, B.; Moorjani, S.; Dagenais, G.R.; Lupien, P.J. 1993: Lipoprotein Lp is an important risk factor in intermittent claudication Evaluation of retrospective and prospective data in 2440 men. Journal of the American College of Cardiology 21(2 Suppl A): 166A

Haupl, T.; Landgraf, S.; Netusil, P.; Biller, N.; Capiau, C.; Desmons, P.; Hauser, P.; Burmester, G.R. 1995: Lipoprotein OspA is a potent stimulator of monocytes and induces early signals suppressing TH1 response. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 583

Manzato, E. 1993: Lipoprotein Which therapy?. Giornale della Arteriosclerosi 18(3): 99-101

Franceschini, G.; Michelagnoli, S. 1990: Lipoprotein a a bridge between arteriosclerosis and thrombosis. Giornale della Arteriosclerosi 15(1): 3-16

Rouy, D.; Chapman, J.; Angles Cano, E. 1990: Lipoprotein a a competitor of the binding and activation of plasminogen at the fibrin surface. Fibrinolysis 4(Suppl 3): 77

Albers, J.J. 1989: Lipoprotein a a genetic marker for atherosclerosis. Clinical Chemistry 35(6): 1234

Utermann, G. 1992: Lipoprotein a a genetic risk factor for chd. Fresenius' Journal of Analytical Chemistry 343(1): 37

Rees, A. 1991: Lipoprotein (a): a possible link between lipoprotein metabolism and thrombosis. British Heart Journal 65(1): 2-3

Simon, D.I.; Schoen, F.J.; Fless, G.M.; Scanu, A.M.; Schmidt, D.A.; Safian, R.D.; Penny, W.F.; Baim, D.S.; Loscalzo, J. 1991: Lipoprotein a accumulates intracellularly in coronary atherectomy specimens obtained from primary and restenotic lesions after ptca. Journal of the American College of Cardiology 17(2 Suppl A): 299A

Mezdour, H.; Parra, H.J.; Aguie-Aguie, G.; Fruchart, J.C. 1990: Lipoprotein (a). An additional marker of atherosclerosis. Annales de Biologie Clinique 48(3): 139-153

Hegele, R.A. 1989: Lipoprotein (a): an emerging risk factor for atherosclerosis. Canadian Journal of Cardiology 5(5): 263-265

Spalding, S.H.; Simpson, N.; Odeh, N.O.; Mcconathy, W.J.; Bowers, M.I.; Black, D.D. 1992: Lipoprotein a and cholesterol screening in an inner city black population. Pediatric Research 31(4 Part 2): 101A

Harpel, P.C. 1992: Lipoprotein a and immunoglobulin g potential modulators of the plasmin enzyme system. Haber, E And E Braunwald (Ed ) Thrombolysis: Basic Contributions And Clinical Progress Xvii+357p Mosby-Year Book, Inc : St Louis, Missouri, Usa; London, England, Uk Illus 113-121

Cressman, M.D.; Hoff, H.F.; Nally, J.V.Jr; Schreiber, M.Jr; Van Lente, F. 1991: Lipoprotein a and the cardiovascular risk of end stage renal disease. Journal of the American Society of Nephrology 2(3): 234

Nowicka, G. 1990: Lipoprotein a as a factor promoting the development of coronary heart disease. Zywienie Czlowieka I Metabolizm 17(1): 70-75

Scanu, A.M. 1991: Lipoprotein a as a marker for coronary heart disease risk. Clinical Cardiology 14(2 Suppl 1): I35-I39

Liakishev, A.A.; Pokrovskiĭ, S.N.; Susekov, A.V. 1991: Lipoprotein (a) as a risk factor in the development of atherosclerosis. Kardiologiia 31(2): 71-75

Scanu, A.M. 1992: Lipoprotein a as a thrombogenic factor. Haber, E And E Braunwald (Ed ) Thrombolysis: Basic Contributions And Clinical Progress Xvii+357p Mosby-Year Book, Inc : St Louis, Missouri, Usa; London, England, Uk Illus 105-111

Neumeier, D.; Nagel, D.; Cremer, P. 1992: Lipoprotein a as predictor of atherosclerotic diseases results from the prospective goettingen risk incidence and prevalence study grips. European Journal of Clinical Investigation 22(4 Part 2): A52

Scanu, A.M. 1992: Lipoprotein a assay the heterogeneity issue. Clinical Chemistry 38(6): 1133-1134

Hoover, R.L.; Yin H Q.; Swift, L.L. 1992: Lipoprotein a binding to human arterial smooth muscle cells. FASEB Journal 6(4): A1040

Ezratty, A.; Simon, D.I.; Loscalzo, J. 1991: Lipoprotein a competitively inhibits plasminogen activation on the platelet surface. Circulation 84(4): II566

Ditzel, J.; Klausen, I.C.; Schmidt, E.B.; Gerdes, L.U.; Lervang H H.; Faergeman, O. 1991: Lipoprotein a concentrations and apoprotein a isoforms in patients with type i diabetes. Diabetologia 34(Suppl 2): A23

Farish, E.; Rolton, H.A.; Barnes, J.F.; Hart, D.M. 1991: Lipoprotein (a) concentrations in postmenopausal women taking norethisterone. Bmj 303(6804): 694

Koskinen, P.; Jauhiainen, M.; Ehnholm, C.; Manttari, M.; Manninen, V.; Huttunen, J.K.; Frick, M.H. 1989: Lipoprotein a did not predict coronary events in the helsinki heart study. Circulation 80(4 Suppl 2): II408

Breckenridge, W.C. 1990: Lipoprotein (a): genetic marker for atherosclerosis?. Cmaj: Canadian Medical Association Journal 143(2): 115

Hegele, R.A.; Williams, R.R.; Lalouel, J.M. 1989: Lipoprotein a genetics in a large utah usa kindred linkage analysis and molecular studies. Clinical Research 37(2): 374A

Scanu, A.M.; Fless, G.M. 1990: Lipoprotein (a). Heterogeneity and biological relevance. Journal of Clinical Investigation 85(6): 1709-1715

Gault, H.; Longerich, L.; Harnett, J.; Prabhakaran, V.; Breckenridge, C. 1993: Lipoprotein a in CAPD, hemodialysis and after transplantation. Journal of the American Society of Nephrology 4(3): 249

Riesen, W.; Robert, D. 1990: Lipoprotein a in chronic uremic patients with and without remnant kidney tissue. Clinical Chemistry 36(6): 958

Stenvinkel, P.; Heimburger, O.; Berglund, L.; Alvestrand, A. 1992: Lipoprotein a in nephrotic syndrome ns. Journal of the American Society of Nephrology 3(3): 320

Pyrros, J.; Rallidis, L.; Papageorgakis, N.; Stamatis, D.; Chatzis, N.; Tsitouris, G. 1992: Lipoprotein a in offsprings of young coronary patients. European Heart Journal 13(ABSTR Suppl): 314

Lyakishev, A.; Olofinskaya, I.; Volkova, E.; Susekov, A.; Pokrovsky, S. 1991: Lipoprotein a in patients with coronary artery disease cad documented by angiography. European Heart Journal 12(ABSTR Suppl): 246

Tsitamidou, R.; Pangalos, E.; Fitili, C.; Tsoulfa, S.; Kontodimou, A. 1994: Lipoprotein a in patients with non-insulin dependent diabetes mellitus with microglobulinuria. Deltion Ellinikis Mikrobiologikis Etaireias 39(6): 628-635

Hahm, K.B.; Kim, W.H.; Lim, D.S.; Chon, C.Y.; Kang, J.K.; Park, I.S.; Choi, H.J.; Shin, Y.H.; Kim, C.J. 1992: Lipoprotein a in patients with various liver diseases. Gastroenterology 102(4 Part 2): A817

Niendorf, A.; Peters, A.; Keilhau, A.; Stang, A.; Nagele, H.; Von Ostau, K.; Hamper, K.; Gebhart, A. 1992: Lipoprotein a in solid tumors parallelism to the distribution pattern in human atheromas. Proceedings of the American Association for Cancer Research Annual Meeting 33: 17

Ginier, P.; Murthy, V.K.; Deedwania, P. 1992: Lipoprotein a in veterans with non insulin dependent diabetes mellitus. Clinical Research 40(1): 44A

Edelberg, J.M.; Conrad, H.E.; Pizzo, S.V. 1991: Lipoprotein a inhibition of heparin enhanced plasminogen activation correlate with heparin oligosaccharide length. Circulation 84(4 Suppl 2): II356

Weinfeld, M.S.; Scanu, A.M.; Fless, G.; Loscalzo, J. 1989: Lipoprotein a inhibits fibrin enhancement of plasminogen activation by t pa. Circulation 80(4 Suppl 2): II181

Kuo, P.; Weinfeld, M.; Scanu, A.M.; Fless, G.; Loscalzo, J. 1990: Lipoprotein a inhibits monocytes surface mediated plasminogen activation by tissue plasminogen activator. Clinical Research 38(2): 470A

Mcconathy, W.; Korner, G.; Trieu, V.; Vlodavsky, I.; Bar Shavit, R. 1989: Lipoprotein a inhibits plasminogen activators resident in the subendothelial extracellular matrix. Journal of Cell Biology 109(4 Part 2): 311A

Ezratty, A.; Simon, D.; Fless, G.; Scanu, A.; Loscalzo, J. 1991: Lipoprotein a inhibits plasminogen binding to platelets. Clinical Research 39(2): 198A

Mcconathy, W.; Bar Shavit, R.; Trieu, V.; Korner, G.; Vlodavsky, I. 1990: Lipoprotein a interactions with the subendothelial extra cellular matrix. FASEB Journal 4(4): A1019

Sorrentino, M.; Vielhauer, C.; Eisenbart, J.D.; Fless, G.; Feldman, T. 1991: Lipoprotein a is higher in white and black patients with coronary artery disease. Clinical Research 39(3): 737A

Wanner, C.; Koester, W.; Riegel, W.; Wieland, H.; Schollmeyer, P. 1991: Lipoprotein a kinetics in patients with the nephrotic syndrome. Journal of the American Society of Nephrology 2(3): 247

Pearson, T.; Davidson, L.; Jenkins, P.; Rybicki, B.; Klag, M.; Thomas, J. 1990: Lipoprotein a levels in blacks versus whites marked differences in levels and correlations with other lipids. Circulation 82(4 Suppl 3): III120

Brugemann, J.; Van Boven, A.J.; Van Der Meer, J.; Hillege, H.; Van Doormaal, J.J.; Lie, K.I. 1992: Lipoprotein a levels in patients with myocardial infarction treated with anistreplase probably no prediction of clinical outcome but impairment of plasminogen activation in non patency. European Heart Journal 13(ABSTR Suppl): 27

Wolffenbuttel, B.H.R.; Heesen, B.J.; Menheere, P.P.C.A.; Rondas Colbers, G.J.W.M.; Donselaar, L.A.M.; Sels, J.P.J.E.; Kruseman, A.C.N. 1992: Lipoprotein a levels in relation to diabetic complications in patients with non insulin dependent diabetes. European Journal of Clinical Investigation 22(4 Part 2): A56

Sechi, L.A.; De Carli, S.; Cavarape, A.; De Marchi, S.; Falleti, E.; Ceriello, A.; Bartoli, E. 1994: Lipoprotein a levels indicate the severity of target-organ damage in essential hypertension. American Journal of Hypertension 7(4 Part 2): 16A

Genest, J.Jr; Jenner, J.L.; Ordovas, J.M.; Silberman, S.R.; Wilson, P.W.F.; Schaefer, E.J. 1990: Lipoprotein a lpa a highly heritable cardiovascular risk factor. Clinical and Investigative Medicine 13(5 Suppl): C83

Eichner, J.E.; Cauley, J.A.; Kamboh, M.I.; Ferrell, R.E.; Kuller, L.H.; Black, D. 1991: Lipoprotein a lpa concentrations in older women distribution and associations with other risk factors. American Journal of Epidemiology 134(7): 749-750

Modi K.S.; Ma J.Z.; Kasiske B.L.; Collins A.J.; Keane W.F. 1992: Lipoprotein a lpa in hemodialysis hd patients. Journal of the American Society of Nephrology 3(3): 380

Levitsky, L.L.; Scanu, A.M.; Gould, S.H. 1990: Lipoprotein a lpa protein levels are related to glycemic control in white diabetic children. Pediatric Research 27(4 Part 2): 191A

Loscalzo, J. 1990: Lipoprotein a modulates fibrinolysis by t pa. Fibrinolysis 4(Suppl 3): 17

Hajjar, K.A.; Gavish, D.; Breslow, J.L.; Nachman, R.L. 1989: Lipoprotein a modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature (London) 339(6222): 303-305

Edelberg, J.M.; Reilly, C.F.; Pizzo, S.V. 1991: Lipoprotein a regulates plasminogen activator inhibitor 1 inhibition of tissue type plasminogen activator. Journal of Cellular Biochemistry Suppl (15 Part C): 118

Rath, M.; Niendorf, A.; Reblin, T.; Krebber, J.; Beisiegel, U.; Greten, H.; Kalmar, P. 1989: Lipoprotein a risk factor with atherogenic and thrombogenic properties a study in serum and arterial wall of 107 coronary bypass patients. European Heart Journal 10(ABSTR Suppl): 314

MBewu, A.D.; Durrington, P.N. 1990: Lipoprotein (a): structure, properties and possible involvement in thrombogenesis and atherogenesis. Atherosclerosis 85(1): 1-14

Scanu, A.M. 1990: Lipoprotein a the knowns and the many unknowns. Journal of Drug Development 3(Suppl 1): 163-166

Edelberg, J.M.; Pizzo, S.V. 1991: Lipoprotein a the link between impaired fibrinolysis and atherosclerosis. Fibrinolysis 5(3): 135-144

Bergesio, F.; Ciuti, R.; Monzani, G.; Frizzi, V.; Sodi, A. 1990: Lipoprotein abnormalities and progression of chronic renal failure. Nephrology Dialysis Transplantation 5(8): 670-671

Pocovi, M.; Sarria, A.; Civeira, F.; Perez Calvo, J.; Giraldo, P.; Giralt, M.; Ordovas, J.M. 1996: Lipoprotein abnormalities in carriers of Gaucher disease, Type I. Blood 88(10 Suppl 1 Part 1-2): 33B

Barbagallo, C.M.; Averna, M.R.; Notarbartolo, A. 1991: Lipoprotein abnormalities in chronic renal failure. Giornale della Arteriosclerosi 16(2): 79-86

James, R.W.; Pometta, D. 1995: Lipoprotein abnormalities in diabetes. Woodford, F P, Davignon, J, Sniderman, A International Congress Series; Atherosclerosis X 767-771

Pertosa, G.; Giancaspro, V.; Resta, F.; Corciulo, R.; Colacicco, A.M.; Capurso, A.; Schena, F.P. 1994: Lipoprotein abnormalities in hemodialysis Improved L-p profiles in patients on high-flux dialysis. Journal of the American Society of Nephrology 5(3): 501

Yildiz, A.; Aras, S.; Akkaya, V.; Turk, S.; Oncul, A.; Uras, A.R.; Sever, M.S.; Nisanci, Y. 1998: Lipoprotein abnormalities in hemodialysis patients and renal transplant recipients. Nephrology Dialysis Transplantation 13(6): A176

Zambon, S.; Manzato, E.; Solini, A.; Sambataro, M.; Brocco, E.; Sartore, G.; Crepaldi, G.; Nosadini, R. 1994: Lipoprotein abnormalities in non-insulin-dependent diabetic patients with impaired extrahepatic insulin sensitivity, hypertension, and microalbuminuria. Arteriosclerosis and Thrombosis: a Journal of Vascular Biology 14(6): 911-916

Stewart, M.W.; Webster, J.; Mitcheson, J.; Humphriss, D.; Berrish, T.; Walker, M.; Laker, M.F. 1995: Lipoprotein abnormalities in normoglycaemic relatives of Type 2 diabetic patients. Diabetologia 38(Suppl 1): A249

Dimény, E.; Fellström, B.; Larsson, E.; Tufveson, G.; Lithell, H. 1992: Lipoprotein abnormalities in renal transplant recipients with chronic vascular rejection. Transplantation Proceedings 24(1): 366

Levy, E.; Bendayan, M.; Thibault, L.; Lambert, M.; Paradis, K. 1995: Lipoprotein abnormalities in two children with minimal biliary excretion. Journal of Pediatric Gastroenterology and Nutrition 20(4): 432-439

Yanagi K.; Nakamura T.; Nozaki S.; Nagai Y.; Funahashi T.; Uemura Y.; Jiao S.; Kameda Takemura K.; Kubo M.; Et Al 1991: Lipoprotein abnormality and incidence of coronary artery disease in patients with familial hypercholesterolemia who are combined with diabetes mellitus. Japanese Circulation Journal 55(Suppl A): 131

Furuyoshi, S.; Tani, N. 1989: Lipoprotein adsorbent and apparatus for removing lipoproteins using the same us patent 4814077 march 21 1989. Official Gazette of the United States Patent and Trademark Office Patents 1100(3): 1633-1634

Corti, M.C.; Barbato, G.M.; Baggio, G. 1997: Lipoprotein alterations and atherosclerosis in the elderly. Current Opinion in Lipidology 8(4): 236-241

Rigas, J.R.; Miller, V.A.; Levine, D.M.; Venkatraman, E.S.; Gill, G.M.; Truglia, J.A.; Warrell, R.P.Jr 1995: Lipoprotein alterations in patients treated with novel retinoids. Proceedings of the American Association for Cancer Research Annual Meeting 36: 506

Christidou, F.; Pangidis, P.; Mavropoulou, E.; Mavromatidis, K.; Atmatzidis, E.; Fitili, C.; Vayonas, G. 1996: Lipoprotein alterations in patients with non insulin dependent diabetes mellitus. Nephrology Dialysis Transplantation 11(6): A124

Ginzinger, D.G.; Dallongeville, J.; Rogers, Q.; Hayden, M.R. 1995: Lipoprotein analysis in a colony of lipoprotein lipase deficient cats. Circulation 92(8): I426

Hamm, H.; Pfalzer, B.; Fabel, H. 1990: Lipoprotein analysis in acute and chronic pleural effusions of inflammatory origin. Chest 98(2 Suppl): 139S

Feskens, E.J.M.; Kalmijn, S.; Krombout, D. 1996: Lipoprotein and 5-year coronary heart disease risk. European Heart Journal 17(ABSTR Suppl ): 398

Scaglione, L.; Werlich, R.; Barberis, P.; Berni, P.; Calvelli, M.; Garavelli, P.L.; Molinari, A.; Troielli, F. 1994: Lipoprotein and Diabetes Mellitus. Archivio di Medicina Interna 46(3): 101-119

Knapp, R.G.; Sutherland, S.E.; Keil, J.E.; Schreiner, P.J.; Klein, R.L. 1993: Lipoprotein and all-cause mortality among elderly black and white men. Circulation 88(4 Part 2): I358

Seriolo, B.; Cutolo, M.; Fasciolo, D.; Accardo, S. 1994: Lipoprotein and anticardiolipin antibody concentrations in rheumatoid arthritis patients. Arthritis and Rheumatism 37(9 Suppl): S248

Mueller, H.M.; Kipp, S.; Ohrloff, C.; Donnerhak, B.; Gross, W.; Maerz, W. 1997: Lipoprotein and apo-E-phenotypes in patients with retinal vascular occlusion. IOVS Investigative Ophthalmology and Visual Science 38(4 Part 1-2): S751

Superko, H.R.; Bortz, W.M.; Albers, J.J.; Wood, P.D. 1989: Lipoprotein and apolipoprotein changes during a controlled trial of caffeinated and decaffeinated coffee drinking in men. Circulation 80(4 Suppl 2): II86

Salmayenli, N.; Guler, K.; Kargi, V.; Erk, O.; Karan, M.A.; Tascioglu, C.; Sivas, A.; Kaysi, A. 1994: Lipoprotein and apolipoprotein concentrations in diabetes mellitus with ketosis Effects of insulin therapy. Medical Science Research 22(5): 333-334

Naether, S.; Deuber, H.J.; Prochnow, D.; Osten, B. 1997: Lipoprotein and apolipoprotein phenotypes in CAPD-patients compared to patients with preterminal renal failure. Blood Purification 15(Suppl 2): 30-31

Matsuyama, T.; Nakahara, C.; Honda, M.; Kamiyama, Y.; Hasegawa, O.; Ito, H.; Hoshinaga, K.; Ogawa, O.; Kawamura, T. 1992: Lipoprotein and apoprotein abnormalities in children undergoing CAPD. Ota, K, Maher, J, Winchester, J, Hiszel, P International Congress Series; Current concepts in peritoneal dialysis: 555-559

Legrelle, M.; Bauduceau, B.; Boillot, J.; Le Guyadec, T.; Mayaudon, H.; Burnat, P.; Yvert, J.P.; Gautier, D. 1994: Lipoprotein and cardiovascular risk factors A study in one hundred thirty-one patients with diabetes mellitus. Semaine des Hopitaux 70(7-8): 191-197

Gylling, H.; Strandberg, T.E.; Tilvis, R.; Miettinen, T.A. 1992: Lipoprotein and cholesterol metabolism in middle-aged and old male cohorts. Circulation 86(4 Suppl 1): I810

Tzanatos, H.; Agroyannis, B.; Fourtounas, C.; Soubassi, L.; Rizos, D.A.; Skoutelis, G.; Bougatsos, G.; Kopelias, I.; Voudiclari, S.; Koutsikos, D. 1997: Lipoprotein and coagulation factors in hemodialysis patients. Nephrology Dialysis Transplantation 12(9): A138

Pantoni, Leonardo; Sarti, Cristina; Pracucci, Giovanni; Vanni, Paola; Di Carlo, Antonio; Ermini, Giuseppe; Ciampi, Giampietro; Vergassola, Rossano; Ghetti, Augusto; Inzitari, Domenico 1997: Lipoprotein and dementia in an elderly population. Journal of the Neurological Sciences 150(Suppl ): S87

Meinertz, H.; Nilausen, K. 1998: Lipoprotein and dietary soy protein. Circulation 98(17): I451

Stefanutti, Claudio; Vivenzio, A.; Mazzarella, B.; Di Giacomo, S.; Colombo, C.; Ricci, G.; Alessandri, C.; Bianciardi, G.; Carducci, A. 1993: Lipoprotein and hemocoagulatory parameters during therapeutic plasmapheresis in homozygous and heterozygous familial hypercholesterolemia. Gotto, A M, Jr, Mancini, M, Richter, W O, Schwandt, P Treatment of severe dyslipoproteinemia in the prevention of coronary heart disease, 4 223-233

Baltzell, J.K.; Wooten, J.T.; Otto, D.A. 1990: Lipoprotein and hepatic lipase in rats fed fish oil relationship to plasma insulin levels. FASEB Journal 4(4): A931

Dugi, K.A.; Dichek, H.L.; Talley, G.D.; BrewerH.B.Jr.; Santamarina Fojo, S. 1992: Lipoprotein and hepatic lipase loop structure Essential role of amphipathic helices for lipase substrate interaction. Circulation 86(4 Suppl 1): I607

Olivetti, C.; Gruden, G.; Veglio, M.; Mormile, A.; Cassader, M.; Perin, P.C.; Pagano, G. 1994: Lipoprotein and insulin treatment in non-insulin-dependent diabetic patients. Diabetologia 37(Suppl 1): A144

Malaguarnera, M.; Giugno, I.; Ruello, P.; Rizzo, M.; Panebianco, M.P.; Tomasello, F.B.; Pistone, G. 1997: Lipoprotein and lipid pattern in diabetic and non diabetic subjects with acute cerebral infarction. European Journal of Clinical Investigation 27(Suppl 1): A30

Coronel, F.; Valor, S.; Gonzales Helgera, J.A.; Herrero, J.A.; Valor, R.; Barrientos, A. 1993: Lipoprotein and lipid profile in CAPD patients. Nephrology Dialysis Transplantation 8(9): 1019-1020

Santos, R.; Furlaneto, C.; Graziosi, P.; Vinagre, C.; Bocchi, E.; Fiorelli, A.; Bellotti, G.; Stolf, N.; Jatene, A.; Maranhao, R. 1994: Lipoprotein and lipid profile of patients submitted to heart transplantation. Journal of Heart and Lung Transplantation 13(1 Part 2): S79

Grossi, S.; Gecele, M.; Francesetti, G.; Meluzzi, A.; Crosignani, A. 1990: Lipoprotein and longevity. Gazzetta Medica Italiana Archivio per le Scienze Mediche 149(10): 339-345

Gylling, H.; Riikonen, S.; Nikkila, K.; Miettinen, T.A. 1995: Lipoprotein and noncholesterol abnormalities in cholestasis of pregnancy, and treatment with guar gum. Gastroenterology 108(4 Suppl): A1078

Lervang, H.H.; Klausen, I.C.; Hoeck, H.; Therkelsen, K.; Lemming, L.; Hansen, P.S.; Ditzel, J. 1994: Lipoprotein and other cardiovascular risk factors in type I diabetic patients with macro- and microalbuminuria. Diabetologia 37(Suppl 1): A195

Connolly, J.O.; Sherwood, R.; Beeso, J.; Peters, T.J.; Scoble, J.E. 1994: Lipoprotein and other risk factors in patients with atherosclerotic renovascular disease. Journal of the American Society of Nephrology 5(3): 327

Inokuchi, T.; Tojyo, Y.; Sasamoto, M.; Mogami, K.; Kameyama, M.; Nishimura, C.; Isogai, S. 1997: Lipoprotein and progression of albuminuria in type 2 diabetes Relationship to fibrinogen level. Diabetologia 40(Suppl 1): A418

Herz, J.; Willnow, T.E. 1995: Lipoprotein and receptor interactions in vivo. Current Opinion in Lipidology 6(2): 97-103

Garg, M.; Vacek, J.L.; Harris, W.S. 1998: Lipoprotein and response to tissue plasminogen activator in patients with acute myocardial infarction. Journal of Investigative Medicine 46(3): 231A

Jendryczka, E.; Sypniewska, G.; Poznanska Linde, H.; Nartowicz, E. 1998: Lipoprotein and serum lipids in patients undergoing chronic haemodialysis. European Journal of Clinical Investigation 28(Suppl 1): A10

Gaeta, G.; Cuomo, S.; Foglia, M.; Iovine, C.; Caruso, S.; Della Grottella, M.R.; Boccalatte, A. 1996: Lipoprotein and serum lipids levels predict familiarity for myocardial infarction in adolescents. European Heart Journal 17(ABSTR Suppl ): 534

Myerson, M.; Weil, H.F.C.; Philbin, E.F.; Groff, A.; Jenkins, P.L.; Nichols, M.; Reed, R.G.; Francis, C.K.; Pearson, T.A. 1997: Lipoprotein and sinking pre-beta lipoprotein band Are they equivalent in their prediction of coronary heart disease?. Circulation 96(8): I656-I657, 10-21/97

Carlander, B. 1962: Lipoprotein and spontaneous lipoprotein lipase activity and inhibition in human plasma. Jour Atherosclerosis Res: 438-451

Chuang, C.Z.; Hecker, M.; Legardeur, B.; Lopez, S.A. 1998: Lipoprotein and/or LDL-cholesterol, as risk factors for coronary heart disease in blacks?. Journal of Investigative Medicine 46(1): 59A

Orth Gomer, K.; Mittleman, M.A.; Schenck Gustafsson, K.; Ryden, L. 1996: Lipoprotein as a determinant of CHD in younger women. Journal of the American College of Cardiology 27(2 Suppl A): 304A

Orth Gomer, K.; Mittleman, M.A.; Schenck Gustafsson, K.; Eriksson, M.; Wamala, S.; Belkic, K.; Kirkeeide, R.; Svane, B. 1996: Lipoprotein as a determinant of coronary heart disease in younger women. European Heart Journal 17(ABSTR Suppl ): 399

Hancu, N.; Netea, M.G.; Veresiu, I.A.; Danciu, A.; Iancu, S. 1995: Lipoprotein as a risk factor for coronary heart disease and hypertension in type II diabetes patients. Diabetologia 38(Suppl 1): A251

Schreiner, P.J. 1994: Lipoprotein as a risk factor for preclinical atherosclerotic disease in a biracial cohort The Atherosclerosis Risk in Communities Study. Chemistry and Physics of Lipids 67-68: 405-410

Ohashi, H.; Oda, H.; Watanabe, S.; Matsuno, Y.; Yokoyama, H.; Ito, H.; Ishiguro, M.; Hirano, T. 1997: Lipoprotein as a risk factor of cardiovascular death in patients on hemodialysis Results of a prospective study. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 206A

Stubbs, P.; Seed, M.; Lane, D.; Collinson, P.; Kendall, F.; Noble, M. 1998: Lipoprotein(a) as a risk predictor for cardiac mortality in patients with acute coronary syndromes. European Heart Journal 19(9): 1355-1364

Vernon, S.M.; Sarembock, I.J.; Ayers, C.R.; Powers, E.R.; Gimple, L.W. 1995: Lipoprotein assayed from frozen serum degrades with time in storage. Journal of the American College of Cardiology 1995(SPEC ISSUE): 76A

Bondjers, G.; Camejo, G.; Fager, G.; Olsson, U. 1992: Lipoprotein binding to arterial proteoglycans Effects on cellular growth. Acta Physiologica Scandinavica Suppl 1992(608): 19

Chiang, C.P.; Caulfield, J.P. 1989: Lipoprotein binding to schistosomula of schistosoma mansoni. FASEB Journal 3(4): A1357

Mann, C.J.; Yen, F.T.; Guermani, L.M.; Delplanque, B.; Bihain, B.E. 1994: Lipoprotein binding to the lipolysis stimulated receptor is initiated by free fatty acid-induced conformational rearrangement of the receptor. Circulation 90(4 Part 2): I406

Caplice, N.M.; Peterson, T.E.; Kleppe, L.S.; Mueske, C.S.; Broze, G.J.; Simari, R.D. 1998: Lipoprotein binds and inactivates tissue factor pathway inhibitor. Circulation 98(17): I2

Nevalainen, P.; Lahtela, J.; Mustonen, J.; Taskinen, M.R.; Pasternack, A. 1997: Lipoprotein changes during subcutaneous or intraperitoneal insulin in IDDM patients on peritoneal dialysis. Diabetologia 40(Suppl 1): A430

Corder, C.N.; Goldberg, M.R.; Alaupovic, P.A.; Price, M.D. 1989: Lipoprotein changes during therapy with pinacidil. Clinical Pharmacology and Therapeutics 45(2): 184

Camps J.; Pizarro I.; Prats E.; La Ville A.; Turner P.; Masana L.; Joven J. 1992: Lipoprotein changes in plasma of alcoholic patients with hepatocellular liver disease. Journal of Hepatology 16(Suppl 1): S83

Motika, D.; Childers, D.; Fenton, J. 1989: Lipoprotein changes in subjects on a modified fasting regimen. Clinical Chemistry 35(6): 1068

Cerda, J.J.; Robbins, F.L.; Burgin, C.W.; Sullivan, M.P.; Bartfield, R.B. 1989: Lipoprotein cholesterol adaptation of microswine fed a high fat high cholesterol diet. Clinical Research 37(2): 329A

Yokoyama, W.H.; Walzem, R.; Xu, R.; German, J.B.uce 1994: Lipoprotein cholesterol analysis by size exclusion chromatography Comparison with sequential equilibrium density ultracentrifugation. FASEB Journal 8(4-5): A449

Bauer, J.E.; Vienne, K. 1991: Lipoprotein cholesterol and hepatic ldl receptor activities of endogenous hypercholesterolemic rabbits supplemented with omega 3 and omega 6 fatty acid containing dietary oils. Simopoulos, A P , Et Al (Ed ) World Review Of Nutrition And Dietetics, Vol 66 Health Effects Of Omega-3 Polyunsaturated Fatty Acids in Seafoods; Meeting, Washington, D C , Usa, March 20-23, 1990 Xxiv+592p S Karger Ag: Basel, Switzerland; New York, New York, Usa Illus 559-560

Noerpramana, N.P.; Hadisaputro, H.; Hadijono, S. 1995: Lipoprotein cholesterol levels in Norplant implant users. Advances in Contraception 11(1): 55-56

Baker, P.R. 1990: Lipoprotein cholesterol levels in breast cyst fluid. Journal of Cancer Research and Clinical Oncology 116(Suppl Part 1): 21

Ryan, D.P.; Williams, G.L. 1992: Lipoprotein cholesterol metabolism growth hormone secretion and ovarian follicular dynamics in postpartum beef cows varying widely in body condition and fed high fat diets. Journal of Animal Science 70(Suppl 1): 26

Zambon, A.; Hokanson, J.E. 1998: Lipoprotein classes and coronary disease regression. Current Opinion in Lipidology 9(4): 329-336

Hughes, T.A.; Gaber, A.O.; Amiri, H.S.; Wang, X.; Elmer, D.S.; Winsett, R.P.; Hathaway, D.K.; Hughes, S.M.; Ghawji, M. 1994: Lipoprotein composition in insulin-dependent diabetes mellitus with chronic renal failure: effect of kidney-pancreas transplantation. Transplantation Proceedings 26(2): 500

Stewart, M.W.; James, R.A.; Kendall Taylor, P.; Laker, M.F. 1993: Lipoprotein compositional abnormalities in acromegaly and non-insulin dependent diabetes mellitus. Journal of Endocrinology 137(Suppl ): P73

Buscaglia, P.; Gazzaruso, C.; Garzaniti, A.; Bonetti, G.; Auguadro, C.; Chioffi, M.; Falcone, C.; Geroldi, D. 1996: Lipoprotein concentration and apo polymorphism in the multifactorial genesis of coronary heart disease. European Heart Journal 17(ABSTR Suppl ): 96

Shi, H.; Fang, J.; Yang, X.; Shen, Z.; Zhu, X. 1998: Lipoprotein concentration and apolipoprotein phenotype in subjects with type 2 diabetes mellitus. Chinese Medical Journal (English Edition) 111(11): 1013-1017

Ergina, F.; Cote, G.; Ciampi, A.; Farrah, B.; Doucet, S.; Bilodeau, L.; Tardif, J.C.; Bonan, R.; Solymoss, B.C. 1996: Lipoprotein concentration does not correlate with angiographic restenosis. Journal of the American College of Cardiology 27(2 Suppl A): 362A-363A

Juergens, G.; Taddei Peters, W.C.; Koeltringer, P.; Petek, W.; Chen, Q.; Greilberger, J.; Macomber, P.F.; Butman, B.T.; Ransom, J.H. 1994: Lipoprotein concentration is a better predictor for risk of cerebrovascular disease than carotid artery stenosis or other lipoprotein levels. Stroke 25(1): 247

Marcovina, S.M.; Albers, J.J.; Jacobs, D.R.; Perkins, L.L.; Lewis, C.E.; Howard, B.V.; Savage, P. 1993: Lipoprotein[a] concentrations and apolipoprotein[a] phenotypes in Caucasians and African Americans. The CARDIA study. Arteriosclerosis and Thrombosis: a Journal of Vascular Biology 13(7): 1037-1045

Auinger, M.; Trenkwalder, E.; Feinboeck, C.; Irsigler, K.; Dieplinger, H.; Kronenberg, F. 1998: Lipoprotein concentrations and apolipoprotein phenotypes in long-lasting IDDM relationship to survival?. Diabetologia 41(Suppl 1): A347

Stober, C.; Mulvaney, A.; Neithercut, D.; Harland, J. 1992: Lipoprotein concentrations in elderly hypercholesterolaemic subjects apparently free from CAD. Medical Laboratory Sciences 49(3): 174

Van Pampus, M.G.; Koopman, M.M.W.; Wolf, H.; Bueller, H.R.; Prins, M.H. 1998: Lipoprotein concentrations in patients with a history of severe preeclampsia; a case control study. Clinical Chemistry 44(6 Part 2): A82

Davis, P.G.; Szymanski, L.M.; Ferguson, M.A.; Alderson, N.L.; Dowda, M.; Pate, R.R.; Durstine, J.L. 1995: Lipoprotein concentrations in physically active and inactive men. Medicine and Science in Sports and Exercise 27(5 Suppl): S69

Cowan, G.S.M.Jr; Buffington, C.K. 1997: Lipoprotein concentrations of the morbidly obese The effects of massive weight loss. FASEB Journal 11(3): A356

Budde, T.; Boesenberg, E.; Fechtrup, C.; Vielhauer, C.; Enbergs, A.; Schulte, H.; Assmann, G.; Breithardt, G. 1993: Lipoprotein correlates with number, severity and extension of coronary lesions in male patients with angiographically documented coronary artery disease. European Heart Journal 14(ABSTR Suppl ): 425

Franklin, B.; Crause, I.; Bonzheim, K.; Berg, T.; Fisher, P.; Bakalyar, D.; Gordon, S.; Timmis, G.C. 1993: Lipoprotein decreases caused by repeated maximal exercise testing in sedentary men. Medicine and Science in Sports and Exercise 25(5 Suppl): S147

Chu, T.; Frautschy, S.A.; Yang, F.; Teter, B.; Chen, P.; Beech, W.; Sigel, J.J.; Howard, B.D.; Cole, G.M. 1997: Lipoprotein dependent A-beta clearance in vivo and in vitro. Society for Neuroscience Abstracts 23(1-2): 1638

Jarmulowicz, M.; Garwood, L.; Dorman, A.; Moorhead, J. 1994: Lipoprotein deposition in renal disease. Journal of Pathology 172(Suppl): 151A

Salafia, C.; Starzyk, K.; Ossandon, M.; Vercruysse, L.; Parkash, V.; Lage, J.; Pijnenborg, R. 1996: Lipoprotein deposition in the uteroplacental bed distinguishes normal and preeclamptic pregnancies. American Journal of Obstetrics and Gynecology 174(1 Part 2): 363

Facchinetti, R.; Ruzzenente, O.; Poli, G.; Guidi, G.C. 1993: Lipoprotein determination Comparison of methods and standardization problems. Giornale Italiano di Chimica Clinica 17(5): 375-385, 1992

Scanu, A.M. 1989: Lipoprotein disorders diagnosis and treatment. Lusis, A J And R S Sparkes (Ed ) Monographs in Human Genetics, Vol 12 Genetic Factors in Atherosclerosis: Approaches And Model Systems X+227p S Karger Ag: Basel, Switzerland; New York, New York, Usa Illus 1-49

Nishino, M.; Redberg, R.F.; Sobol, Y.; Burleson, K.; Malloy, M.; Russell, J.; Kane, J. 1998: Lipoprotein does not correlate with coronary calcium deposits in postmenopausal women. Journal of the American College of Cardiology 31(2 Suppl A): 130A

Chou, T.M.; Messenger, J.C.; Naya Vigne, J.; Durairaj, A.; Ko, E.; Zellner, C.A.; Sudhir, K.; Malloy, M.J.; Kane, J.P. 1997: Lipoprotein does not correlate with early atherosclerosis as seen on intracoronary ultrasound in asymptomatic familial hyperlipidemia. Journal of the American College of Cardiology 29(2 Suppl A): 232A

Barth, J.A.; Deckelbaum, R.J.; Starc, T.J.; Cohn, L.; Shea, S.; Mosca, L.; Berglund, L. 1996: Lipoprotein does not predict family history of early heart disease in hyperlipidemic children. Pediatric Research 39(4 Part 2): 22A

Usher, D.; Leef, K.; Spear, M.L. 1994: Lipoprotein during fat infusions and transition to enteral feeding in premature infants. Pediatric Research 35(4 Part 2): 322A

Sturley, S.L.; Attie, A.D. 1990: Lipoprotein expression in saccharomyces cerevisiae. Journal of Cellular Biochemistry Suppl (14 Part C): 68

Deev, A.; Shestov, D.; Zhukovsky, G.; Abolafia, J.; Kim, H.; Davis, C.E.; Tyroler, H.A. 1990: Lipoprotein fractions do not predict mortality similarly in usa and ussr lrc women. Circulation 82(4 Suppl 3): III346

Mourad, G.; Cristol, J.P.; Turc-Baron, C.; Djamali, A. 1997: Lipoprotein glomerulopathy: a new apolipoprotein-E-related disease that recurs after renal transplantation. Transplantation Proceedings 29(5): 2376

Saito, T.; Sato, H.; Oikawa, S.; Kudo, K.; Kurihara, I.; Nakayama, K.; Abe, K.; Yoshinaga, K.; Sakaguchi, H. 1993: Lipoprotein glomerulopathy. Report of a normolipidemic case and review of the literature. American Journal of Nephrology 13(1): 64-68

Saito, T.; Oikawa, S.; Sato, H.; Chiba, J. 1997: Lipoprotein glomerulopathy and its pathogenesis. Contributions to Nephrology 120: 30-38

Lyons, T.J. 1992: Lipoprotein glycation and its metabolic consequences. Diabetes 41(Suppl 2): 67-73

Kozak, M. 1996: Lipoprotein has no influence on restenosis or reocclusion rate after nonsurgical recanalisation procedures in peripheral arteries. International Angiology 15(2 Suppl 1): 44

Leerink, B.C.; Duif, P.; Gimpel, J.A.; Kortlandt, W.; Van Rijn, H.J.M. 1992: Lipoprotein heterogeneity Lysine binding and inhibition of plasminogen activation. Gotto, A M Jr , et al Treatment of severe dyslipoproteinemia in the prevention of coronary heart disease; 3rd International Symposium, Munich, Germany, October 17-18, 1990 ix+366p S Karger AG: Basel, Switzerland; New York, New York, USA Illus ISBN 3-8055-5539-3: 108-112

Matsuura, S.; Adachi, H.; Ushio, Y.; Kobatake, S.; Mallory, T. 1996: Lipoprotein immunoturbidimetric assay on an routine automated analyzer. Clinical Chemistry 42(6 Part 2): S112

Wilmink, Hanneke W.; De Kleijn, Miriam J.; Banga, Jan D.; Bots, Michiel L.; Bak, Annette A.; Van Der Schouw, Yvonne T.; Grobbee, Diederick E. 1998: Lipoprotein impairs endothelial function in healthy postmenopausal women. Circulation 98(17): I242

Querfeld, U.; Lang, M.; Kohl, B.; Fiehn, W.; Schaerer, K. 1992: Lipoprotein in children with chronic renal diseases. Pediatric Nephrology 6(5): C180

Zwolinska, D.; Szprynger, K.; Berny, U.; Morawska, Z. 1996: Lipoprotein in children with chronic renal failure. Nephrology Dialysis Transplantation 11(6): A139

Salafia, C.M.; Starzyk, K.A.; Ossandon, M.; Vercruysse, L.; Parkash, V.; Lage, J.; Pijnenborg, R. 1996: Lipoprotein in distal uteroplacental vessels High level expression associated with non-hypertensive prematurity. American Journal of Obstetrics and Gynecology 174(1 Part 2): 362

Obara, Y. 1992: Lipoprotein in human cataractous lens. Experimental Eye Research 55(Suppl 1): S205

Sharaf Eldin, U.A.; Mansour, M.; Soliman, A.R.; Fouad, H.; El Herizy, W.; Francis, M.R. 1996: Lipoprotein in idiopathic nephrotic syndrome Study of different histopathological types. Nephrology Dialysis Transplantation 11(6): A107

Yucemen, N.; Tascilar, N.; Erdogan, M. 1998: Lipoprotein in levels in stroke subtypes in Turkish population. European Journal of Neurology 5(Suppl 1): S23-S24

Rallidis, L.; Pyrros, J.; Papageorgakis, N.; Flessas, L.; Krespi, P.; Tsitouris, G. 1993: Lipoprotein in men with low total cholesterol and coronary artery disease. European Heart Journal 14(ABSTR Suppl ): 382

Koch, M.; Bollmann, S.; Kutkuhn, B.; Grabensee, B. 1995: Lipoprotein in patients with end stage renal disease. Journal of the American Society of Nephrology 6(3): 543

Mota,A.P.L.; Carvalho,M.dasG.; Lima,L.M.; Santos,M.E.R.deC.; Sousa,M.deO. 2008: Lipoprotein in patients with peripheral arterial obstructive disease and/or type 2 diabetes mellitus. Jornal Brasileiro De Patologia E Medicina Laboratorial: 2, 89-95

Bartens, W.; Zimmermann, J.; Schramm, L.; Heidbreder, E.; Wanner, C. 1995: Lipoprotein in patients with type I and type II diabetes mellitus and various degrees of nephropathy. Journal of the American Society of Nephrology 6(3): 446

Lamonte, M.; Usher, D.; Golden, M.; Carpenter, J.; Zager, E.; Roberts, S.; Rader, D. 1998: Lipoprotein in plasma and tissue of carotid endarterectomy patients. Neurology 50(4 Suppl 4): A292

Jendryczka, E.; Sypniewska, G.; Poznanska Linde, H.; Nartowicz, E. 1998: Lipoprotein in relation to serum albumin as an independent risk factor for atherosclerosis in heamodialyzed patients. European Journal of Clinical Investigation 28(Suppl 1): A10

Stenvinkel, P.; Heimburger, O.; Pettersson, E.; Berglund, L.; Alvestrand, A. 1993: Lipoprotein in renal disease. Journal of the American Society of Nephrology 4(3): 258

Salafia, C.M.; Starzyk, K.; Lage, J.; Ossandon, M.; Vercruysse, L.; Parkash, V.; Spong, C.Y.; Pijnenborg, R. 1996: Lipoprotein in spiral arteries at term and after placental delivery Can involution-related processes begin before parturition?. American Journal of Obstetrics and Gynecology 174(1 Part 2): 369

Deepa, R.; Mohan, V.; Premalatha, G.; Sastri, N.G.; Karkuzhali, K. 1997: Lipoprotein in urban South Indian NIDDM patients with ischaemic heart disease. Diabetologia 40(Suppl 1): A423

Greiber, S.; Gutenkunst, M.; Pavenstaedt, H.; Galle, J.; Schollmeyer, P.; Wanner, C. 1994: Lipoprotein induces rat mesangial cell proliferation Role of oxygen radicals. Journal of the American Society of Nephrology 5(3): 942

Tyshkov, M.; Pritchard, K.A.; Schwarz, S.M. 1991: Lipoprotein influences on endothelial cell lipid dynamics and membrane function. Pediatric Research 29(4 Part 2): 115A

Angles Cano, E.; Hervio, L.; Thillet, J.; Loyau, S.; Chapman, J.M. 1992: Lipoprotein inhibition of fibrinolysis is related to apolipoprotein isoform. Circulation 86(4 Suppl 1): I734

Fard, A.K.; Zhong, J.; Dubois, D.D.; Ditullio, M.R.; Berglund, L.; Cannon, P. 1998: Lipoprotein inhibits endothelial cell nitric oxide synthesis. Circulation 98(17): I117

Ezratty, A.M.; Simon, D.I.; Fless, G.M.; Scanu, A.M.; Loscalzo, J. 1993: Lipoprotein inhibits fibrinogen uptake and degradation by mononuclear cells. Clinical Research 41(2): 183A

Traill, K.N.; Huber, L.A.; Wick, G.; Jürgens, G. 1990: Lipoprotein interactions with T cells: an update. Immunology Today 11(11): 411-417

Potts, J.L.; Fisher, R.M.; Coppack, S.W.; Gibbons, G.F.; Frayn, K.N. 1990: Lipoprotein interconversions during passage through subcutaneous adipose tissue in humans in vivo. Biochemical Society Transactions 18(6): 1196-1197

Wahn, F.; Daniel, V.; Opelz, G.; Wiesel, M.; Michalk, D.; Querfeld, U. 1998: Lipoprotein is a risk factor for chronic renal transplantation rejection. Pediatric Nephrology 12(7): C202

Schlaich, M.P.; Leidig, M.; Klingbeil, A.; Schmieder, R.E. 1998: Lipoprotein is already increased in moderate and severe stages of chronic renal failure. Kidney and Blood Pressure Research 21(2-4): 187

Cecchin, E.; De Marchi, S.; Falleti, E.; Adorati, M.; Sepiacci, G.; Spulzaro, P.; Zanello, F.; Gonano, F.; Bartoli, E. 1998: Lipoprotein is an independent predictor of mortality from atherothrombotic vascular events in hemodialysis patients A 5-year prospective study. Nephrology Dialysis Transplantation 13(6): A201

Nowak Goettl, U.; Junker, R.; Muenchow, N.; Roetrige, B.; Schneppenheim, R.; Weber, D.; Von Eckardstein, A. 1998: Lipoprotein is an independent risk factor of childhood thromboembolism A multicentre case-control study. Annals of Hematology 76(Suppl 1): A8

Lloyd, G.W.; Jackson, G.; Boersma, E.; Foley, D.; Serruys, P.W. 1998: Lipoprotein is not associated with restenosis in subjects undergoing elective conventional coronary balloon angioplasty. Circulation 98(17): I513

Wood, G.N.I.; Bhatnagar, D.; Mackness, M.I.; Short, C.D.; Durrington, P.N.; Gokal, R. 1996: Lipoprotein is the interstitial fluid and serum of patients with chronic renal failure and matched controls. Journal of the American Society of Nephrology 7(9): 1326

Kim, J.Y.; Kim, M.S.; Kim, J.M.; Park, J.H.; Lee, J.H.; Yang, S.W.; Chung, D.J.; Chung, M.Y.; Lee, T.H. 1998: Lipoprotein level and vascular complications in NIDDM. Shinn, S H, Shichiri, M, Kim, K -W International Congress Series; Recent advances on the pathogenesis and management of diabetes mellitus 248-252

Chung, M.Y.; Kim, J.Y.; Yang, S.W.; Chung, D.J.; Lee, T.H. 1997: Lipoprotein level and vascular complications in non-insulin dependent diabetes mellitus. Diabetologia 40(Suppl 1): A422

Santos, R.; Borba, E.; Vinagre, C.; Bonfa, E.; Luz, P.D.; Pileggi, F.; Maranhao, R. 1993: Lipoprotein level is elevated in systemic lupus erythematosus. European Heart Journal 14(ABSTR Suppl ): 361

Borba, E.; Santos, R.; Bonfa, E.; Vinagre, C.; Rodrigues, R.; Latrilha, C.; Goncalves, C.; Maranhao, R.; Cossermelli, W. 1992: Lipoprotein level is increased in systemic lupus erythematosus. Arthritis and Rheumatism 35(9 Suppl): S131

Taddei Peters, W.C.; Macomber, P.F.; Jurgens, G.; Wiklund, O.; Koeltringer, P.; Petek, W.; Linden, T.; Chen, Q.; Ulstrom, C.; Butman, B.T.; Ransom, J.H. 1994: Lipoprotein levels and apolipoprotein isoforms differ among ethnic populations. FASEB Journal 8(4-5): A403

Alos, N.; Huot, C.; Pometta, M.; Thibault, L.; Lambert, M.; Gonthier, M.; Levy, E. 1996: Lipoprotein levels and composition in childhood insulin dependent diabetes. Hormone Research 46(Suppl 2): 55

Wolffenbuttel, B.H.R.; Heesen, B.J.; Leurs, P.B.; Menheere, P.P.C.A.; Sels, J.P.J.E.; Kruseman, A.C.N.euwenhuijzen 1992: Lipoprotein levels and diabetic complications in patients with type 2 diabetes mellitus. Netherlands Journal of Medicine International Edition 41(3-4): A27

Hong, S.Y.; Yang, D.H. 1994: Lipoprotein levels and fibrinolytic activity in patients with nephrotic syndrome. Journal of the American Society of Nephrology 5(3): 331

Yamamoto, M.; Tsukiyama, K.; Ishizaki, H.; Yokoi, T. 1997: Lipoprotein levels and glycemic control in NIDDM subjects. Diabetologia 40(Suppl 1): A420

Perez, A.; Caixas, A.; Chico, A.; Bonet, R.; Rigia, M.; Arroyo, J.A.; De Leiva, A. 1995: Lipoprotein levels and glycemic control in type 2 diabetic subjects. Diabetologia 38(Suppl 1): A250

Falco, C.; Estelles, A.; Cano, A.; Espana, F.; Gilabert, J.; Grancha, S.; Aznar, J. 1998: Lipoprotein levels and isoforms and fibrinolytic activity in postmenopause Influence of hormone replacement therapy. Fibrinolysis and Proteolysis 12(Suppl 1): 41

Hernandez, E.; Praga, M.; Araque, A.; Alcazar, J.J.; Merino, M.J.; Morales, J.M.; Ruilope, L.M.; Rodicio, J.L. 1994: Lipoprotein levels and vascular access survival on chronic hemodialysis. Journal of the American Society of Nephrology 5(3): 415

Santos, R.; Foronda, A.; Foronda, G.; Maranhao, R. 1997: Lipoprotein levels are increased in patients with pulmonary arterial hypertension. European Heart Journal 18(ABSTR Suppl ): 529

Carreras, G.; Caixas, A.; Llopart, R.; Bonet, R.; Caballero, A.; Pou, J.M.; Perez, A. 1995: Lipoprotein levels are not related to glycemic control in diabetic children and adolescents. Diabetologia 38(Suppl 1): A26

Barraud, P.; Albuisson, E.; Jouanel, P.; Lusson, J.R.; Berenfeld, A.; Chapel, I.; Lamaison, D.; Cassagnes, J. 1994: Lipoprotein levels are related to the presence or absence of angiographic coronary artery disease Results from a cohort of 800 patients. Circulation 90(4 Part 2): I509

Barraud, P.; Albuisson, E.; Jouanel, P.; Lusson, J.R.; Schandrin, C.; Chapel, I.; Lamaison, D.; Cassagnes, J. 1994: Lipoprotein levels are related to the presence/absence of angiographic coronary artery disease Results from a cohort of 800 patients. Journal of the American College of Cardiology 1994(SPEC ISSUE): 431A

Seriolo, B.; Accardo, S.; Garnero, A.; Sulli, A.; Cutolo, M. 1997: Lipoprotein levels correlate with acute phase reactants in rheumatoid arthritis patients with anticardiolipin antibody positivity. Arthritis and Rheumatism 40(9 Suppl): S149

Brown, H.; Murphy, B.; Douglas, A.; Anwar, N.; Mackness, M.; Short, C.; Bhatnagar, D.; Durrington, P.; Doherty, C. 1993: Lipoprotein levels following renal transplantation Influence of immunosuppression. Nephrology Dialysis Transplantation 8(9): 1037

Pastor, R.; Gutierrez, C.; Vendrell, J.; Simon, I.; Richart, C. 1993: Lipoprotein levels in NIDDM population. Clinical Chemistry 39(6): 1128

Pastor, R.; Gutierrez, C.; Broch, M.; Llor, C.; Vendrell, J.; Richart, C. 1995: Lipoprotein levels in diabetic population. Diabetologia 38(Suppl 1): A250

Malaguarnera, M.; Rizzo, M.; Panebianco, M.P.; Ruello, P.; Giugno, I.; Restuccia, S. 1997: Lipoprotein levels in diabetic subjects with and without ictus cerebri. Diabetologia 40(Suppl 1): A419

Pulzer, F.; Kratzsch, J.; Rassoul, F.; Richter, V.; Kiess, V.; Keller, E. 1998: Lipoprotein levels in formerly small for gestational age infants. Hormone Research (Basel) 50(Suppl 3): 7

Oymak, O.; Erdem, Y.; Yasavul, U.; Turgan, C.; Caglar, M.; Bakkaloglu, M.; Caglar, S. 1994: Lipoprotein levels in haemodialysis and renal transplant patients. Nephrology Dialysis Transplantation 9(8): 1054-1055

Nicolosi, R.J.; Ausman, L.M.; Hegsted, D.M. 1989: Lipoprotein levels in monkeys fed a diet containing rice oil. Circulation 80(4 Suppl 2): II86

Llor, C.; Richart, C.; Vendrell, J.J.; Gutierrez, C.; Satue, B.; Cots, M. 1997: Lipoprotein levels in obese subjects with and without non-insulin dependent diabetes mellitus. Diabetologia 40(Suppl 1): A210

Averna, M.R.; Marcovina, S.; Krul, E.S.; Schonfeld, G. 1994: Lipoprotein levels in the familial hypobetalipoproteinemias associated with truncated forms of apolipoprotein B. Clinical Research 42(2): 175A

Samkova, H.; Zeller, K.; Yeh, G.; Miller, M. 1998: Lipoprotein lipase -93T/G transition and apo A-I Plattsburgh Two distinct mutations in a family with low HDL-C and premature coronary artery disease. Journal of the American College of Cardiology 31(2 Suppl A): 147A

Morin, C.L.; Schaepler, I.R.; Eckel, R.H. 1994: Lipoprotein lipase DNAprotein interactions are modified by tumor necrosis factor-alpha in 3T3-L1 adipocytes at the proximal promoter. Journal of Cellular Biochemistry Suppl 1994(18 Part A): 163

Auwerx, J.; Leroy, P.; Schoonjans, K. 1992: Lipoprotein lipase: recent contributions from molecular biology. Critical Reviews in Clinical Laboratory Sciences 29(3-4): 243-268

Olivecrona, T.,. Guoqing Liu; Hultin, M.; Bengtsson Olivecrona, G. 1993: Lipoprotein lipase Regulation of the enzyme and its action. Gotto, A M , Jr , Mancini, M , Richter, W O , Schwandt, P Treatment of severe dyslipoproteinemia in the prevention of coronary heart disease, 4 37-44

Eckel, R.H. 1989: Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. New England Journal of Medicine 320(16): 1060-1068

Henriksen, F.L.; Krogh, L.; Horder, M.; Beck Nielsen, H. 1998: Lipoprotein lipase activities, gene mutations, fasting and postprandial lipoproteins in males with NIDDM or AMI. European Journal of Endocrinology 138(Suppl 1): 10

Herminghuysen, D.; Cook, C.; Nair, R.; Bagby, G.; Prasad, C. 1993: Lipoprotein lipase activity and endogenous fat preference Differences in epididymal fat, heart, and brown adipose tissues from high and low fat preferring rats. Clinical Research 41(4): 786A

Graulet, B.; Hocquette, J.F.; Bauchart, D. 1996: Lipoprotein lipase activity and gene expression in heart and skeletal muscles in the preruminant calf. Proceedings of the Nutrition Society 55(1): 18A

Tabe, T.; Ohtsubo, Y.; Takenouchi, K.; Uchida, Y.; Yasumoto, Y.; Yamashita, W.; Arima, T. 1995: Lipoprotein lipase activity and mass in hemodialysis patients. Journal of the American Society of Nephrology 6(3): 589

Zmuda, J.M.; Podl, T.P.; Yurgalevitch, S.M.; Fahrenbach, M.C.; Bausserman, L.L.; Terry, R.B.; Thompson, P.D. 1993: Lipoprotein lipase activity and plasma triglyceride clearance are elevated in endurance trained women. Medicine and Science in Sports and Exercise 25(5 Suppl): S191

Faulconnier, Y.; Chilliard, Y. 1995: Lipoprotein lipase activity in bovine and ovine adipose tissue explants Effects of insulin and/or dexamethasone. Proceedings of the Nutrition Society 54(1): 40A

Duran, D.; Macarulla, M.T.; Portillo, M.P. 1998: Lipoprotein lipase activity in epididymal adipose tissue from rats fed diets which provided different lipid sources. International Journal of Obesity 22(Suppl 3): S178

Murase, T.; Mochizuki, S.; Yamaoka, H.; Nagano, M. 1991: Lipoprotein lipase activity in isolated perfused hearts of streptozotocin induced diabetic rats. Nagano, M And N S Dhalla (Ed ) The Diabetic Heart; International Symposium, Tokyo, Japan, October 1989 Xxv+533p Raven Press: New York, New York, Usa Illus 409-414

Hocquette, J.F.; Brazi, S.; Olivecrona, T.; Bengtsson Olivecrona, G.; Geay, Y. 1995: Lipoprotein lipase activity in muscular and adipose tissues from normal and double-muscled growing calves. Proceedings of the Nutrition Society 54(1): 42A

Speake, B.K.; Noble, R.C.; McCartney, R. 1992: Lipoprotein lipase activity in tissues of the developing chick embryo. Biochemical Society Transactions 20(3): 295s

Querfeld, U.; Eifinger, F.; Gradehand, A.; Michalk, D. 1995: Lipoprotein lipase activity is decreased by parathormone in mature 3T3-L1 adipocytes. Journal of the American Society of Nephrology 6(3): 968

Kasteline, J.J.P.; Wouter Jukema, J.; Van Bouven, A.J.; Jansen, H.; Zwinderman, A.H.; Rabelink, T.J.; Peters, R.J.G.; Lie, K.I.; Bruschke, A.V.G.; Hayden, M.R. 1998: Lipoprotein lipase activity is decreased in CAD patients and inversely correlated with severity of angina pectoris and silent myocardial ischemia. Circulation 98(17): I739

Ewart, H.S.; Carroll, R.; Severson, D.L. 1997: Lipoprotein lipase activity is stimulated in rat cardiomyocytes by insulin and dexamethasone. Journal of Molecular and Cellular Cardiology 29(6): A160

Parthasarathy, N.; Goldberg, I.J.; Sivaram, P.; Wagner, W.D. 1995: Lipoprotein lipase affinity chromatography A procedure to isolate heparin oligosaccharides enriched in 2-O-sulfated hexuronic acid, characteristic of antiproliferative activities. FASEB Journal 9(4): A659

Wolf, H.J.; Schnetzer, A. 1993: Lipoprotein lipase and LDL receptors in human fetal membranes at term. Placenta 14(4): A83

Iverson, S.J.; Hamosh, M.; Bowen, W.D. 1993: Lipoprotein lipase and efficient fat transfer during lactation in grey seals. FASEB Journal 7(3-4): A201

Olivecrona, T.; Bengtsson Olivecrona, G. 1993: Lipoprotein lipase and hepatic lipase. Current Opinion in Lipidology 4(3): 187-196

Nestor, A.; Trayhurn, P. 1994: Lipoprotein lipase and insulin-sensitive glucose transporter gene expression in tissues of lean and obese mice exposed acutely to cold. Proceedings of the Nutrition Society 53(3): 90A

Goldberg, I.J.; Sivaram, P.; Choi, S.Y.; Parthasarathy, N.; Wagner, W.D. 1995: Lipoprotein lipase binding to endothelial cells Specific protein-protein and glycosaminoglycan interactions. Woodford, F P , Davignon, J , Sniderman, A International Congress Series; Atherosclerosis X 246-249

Vilella, E.; Joven, J. 1991: Lipoprotein lipase binding to plasma lipoproteins. Medical Science Research 19(4): 111-112

Choi, S.Y.; Sivaram, P.; Walker, D.E.; Curtiss, L.K.; Goldberg, I.J. 1994: Lipoprotein lipase binds to the amino terminal region of apolipoprotein B. Clinical Research 42(2): 198A

Tsai, E.C.; Brown, J.A.; Veldee, M.S.; Anderson, G.J.; Chait, A.; Brunzell, J.D. 1994: Lipoprotein lipase deficiency and pregnancy Prevention of essential fatty acid deficiency and pancreatitis. Circulation 90(4 Part 2): I75

Wagner, W.D.; Goldberg, I.J.; Parthasarathy, N.; Bottoms, J.D. 1997: Lipoprotein lipase enhances binding of decorin but not biglycan to low density lipoprotein. Circulation 96(8): I39-I40, 10-21/97

Williams, K.J.; Fless, G.M.; Petrie, K.; Snyder, M.L.; Brocia, R.W.; Swenson, T.L. 1991: Lipoprotein lipase enhances cellular catabolism of lipoprotein a. Circulation 84(4): II566

Mamputu, J.C.; Renier, G. 1996: Lipoprotein lipase enhances human monocyte adhesion to endothelial cells. Clinical and Investigative Medicine 19(4 Suppl): S4

Auerbach, B.J.; Caine, W.; Usher, D.; Newton, R.S.; Bisgaier, C.L.; Saxena, U. 1996: Lipoprotein lipase enhances the binding of lipoprotein to endothelial matrix. Circulation 94(8): I38

Mulder, M.; Jansen, H.; Van Berkel, T.J.C.; Frants, R.R.; Havekes, L.M. 1992: Lipoprotein lipase enhances the cellular binding and uptake of VLDL and LDL via the interaction of LPL with heparan sulphate proteoglycans. Circulation 86(4 Suppl 1): I155

Huey, P.J.U.; Marcell, T.; Owens, G.C.; Schaller, K.; Eckel, R.H. 1997: Lipoprotein lipase enhances the uptake and utilization of exogenous triglycerides by immortalized Schwann cells. Society for Neuroscience Abstracts 23(1-2): 65

Hamosh, M.; Mao, J.; Ellis, L.; Hamosh, P. 1991: Lipoprotein lipase enzyme stability is greater in milk than in blood and tissues. FASEB Journal 5(5): A1288

Renier, G.; Skamene, E.; Radzioch, D. 1992: Lipoprotein lipase expression and secretion in inbred mouse strains differing in their susceptibility to atherosclerosis. Journal of Cellular Biochemistry Suppl (16 Part A): 24

Creedon, G.M.; Sexton, D.M.; Collins, P.B. 1996: Lipoprotein lipase expression in human monocyte-derived macrophages. Biochemical Society Transactions 24(1): 68s

Enerbäck, S.; Gimble, J.M. 1993: Lipoprotein lipase gene expression: physiological regulators at the transcriptional and post-transcriptional level. Biochimica et Biophysica Acta 1169(2): 107-125

Raynolds, M.V.; Awald, P.D.; Eckel, R.H. 1989: Lipoprotein lipase gene expression in cultured adipocytes is regulated by insulin and isoproterenol through different mechanisms. Circulation 80(4 Suppl 2): II78

Julien, P.; Savanurmath, C.J.; Halappanavar, S.P.; Ven Murthy, M.R.; Levesque, G.; Cadelis, F.; Gagne, C.; Lupien, P.J. 1995: Lipoprotein lipase gene haplotypes and dyslipoproteinemias Study of a French-Canadian cohort. Woodford, F P , Davignon, J , Sniderman, A International Congress Series; Atherosclerosis X 254-257

Low, P.S.; Saha, N.; Tay, J.S.H.; Arulkumaran, S. 1996: Lipoprotein lipase gene influences plasma lipids in Indian newborns. American Journal of Human Genetics 59(4 Suppl): A368

Sing, K.; Ballantyne, C.M.; Ferlic, L.; Brugada, R.; Dunn, K.J.; Herd, J.A.; Pownall, H.J.; Gotto, M.; Marian, A.J. 1998: Lipoprotein lipase gene mutations, plasma lipid levels, progression/regression of coronary atherosclerosis, response to therapy, and future clinical events. Circulation 98(17): I532

Sawano, M.; Watanabe, Y.; Ohmura, H.; Shimada, K.; Mokuno, H.; Daida, H.; Yamaguchi, H. 1998: Lipoprotein lipase gene polymorphism Associations with coronary artery disease and lipoprotein levels in Japanese population. Journal of the American College of Cardiology 31(2 Suppl A): 148A

Anderson, J.L.; King, G.J.; Elmer, S.P.; Bair, T.L.; Muhlestein, J.B.; Carlquist, J.F. 1998: Lipoprotein lipase gene polymorphisms are predictors of risk of coronary artery disease and myocardial infarction. Journal of the American College of Cardiology 31(2 Suppl A): 147A-148A

Majid, A.; Morgan, R.; Thomas, A.; Rees, A. 1996: Lipoprotein lipase gene variants in susceptibility to coronary artery disease. Clinical Science (London) 90(2): 12P

Simsolo, R.B.; Ong, J.M.; Kern, P.A. 1992: Lipoprotein lipase glycosylation Effects on activity, secretion, and degradation in primary cultures of rat adipocytes. Circulation 86(4 Suppl 1): I607

Eckel, R.H.; Raynolds, M.V.; Bessesen, D.H.; Farese, R.V.Jr; Ohtake, A.; Yost, T.J. 1990: Lipoprotein lipase hormonal and nutritional regulation. Journal of Drug Development 3(Suppl 1): 91-94

Blaner, William S.; Obunike, Joseph C.; Al Haideri, Maysoon; Sasaki, Atsuko; Deckelbaum, Richard J.; Goldberg, Ira J. 1993: Lipoprotein lipase hydrolyses retinyl ester and increases retinoid uptake by cells. Circulation 88(4 Part 2): I179

Deeb, S.S.; Brunzell, J.D. 1998: Lipoprotein lipase in familial combined hyperlipidemia. Journal of Investigative Medicine 46(1): 117A

Creedon, G.; Sexton, D.; Griffin, M.; O'Meara, N.; Collins, P. 1997: Lipoprotein lipase in human monocyte-derived macrophages isolated from type Ii diabetic subjects. Biochemical Society Transactions 25(1): 134s

Sebotkova, E.; Gasperikova, D.; Bohov, P.; Langer, P.; Clandinin, M.T.; Klimes, I. 1997: Lipoprotein lipase in muscle of hHTg rat is related to fatty acid composition of muscle phospholipids. Diabetologia 40(Suppl 1): A247

Peinado, J.; Vilaro, S.; Burgaya, F.; Vilanova, J.; Robert, M.; Ramirez, I.; Llobera, M. 1990: Lipoprotein lipase in newborn rat liver cellular localization and site of synthesis. Cuezva, J M , A M Pascual-Leone And M S Patel (Ed ) Reproductive Biology: Endocrine And Biochemical Development Of The Fetus And Neonate; Annual Meeting Of The Perinatal Biochemical Group Of The Spanish Biochemical Society, Madrid, Spain, December 15-16, 1988 Ix+316p Plenum Press: New York, New York, Usa; London, England, Uk Illus 255-258

Bessesen, D.H.; Richards, C.L.; Eckel, R.H. 1992: Lipoprotein lipase in the spinal cord responds to feeding is increased in obese rats and functions in the uptake of dietary fat. Journal of Cellular Biochemistry Suppl (16 Part B): 263

Clee, S.M.; Zhang, H.; Benlian, P.; Maio, L.; Bissada, N.; Shen, G.X.; Angel, A.; Leboeuf, R.C.; Hayden, M.R. 1996: Lipoprotein lipase increases HDL levels in mice expressing cholesterol ester transfer protein. Circulation 94(8): I399

Medh, J.D.; Bowen, S.L.; Fry, G.L.; Pladet, M.; Andracki, M.; Inoue, I.; Lalouel, J.M.; Strickland, D.K.; Chappell, D.A. 1995: Lipoprotein lipase induces cellular catabolism of lipoproteins via LDL receptors in vitro. FASEB Journal 9(6): A1496

Renier, G.; Skamene, E.; Radzioch, D. 1993: Lipoprotein lipase induces tumor necrosis factor alpha gene expression in macrophages. Clinical and Investigative Medicine 16(4 Suppl): B8

Ibanez,A.J.; Peinado-Onsurbe,J.; Sanchez,E.; Cerda-Reverter,J.M.; Prat,F. 2008: Lipoprotein lipase is highly expressed and active in the ovary of European sea bass , during gonadal development. Comparative Biochemistry And Physiologylecular and Integrative Physiology: 3, 347-354

Laugier, V.B.; Ben Zeev, O.; Doolittle, M.H. 1996: Lipoprotein lipase is misfolded in combined lipase deficiency. Circulation 94(8): I153

De Beer, Femke; De Man, Frits H.A.F.; Smelt, Augustinus H.M.; Van Der Laarse, Arnoud; Havekes, Louis M. 1997: Lipoprotein lipase is required for the binding of very low density lipoproteins to heparan sulphate proteoglycans. Circulation 96(8): I109, 10-21/97

Newnham, H.H.; Barter, P.J. 1990: Lipoprotein lipase lpl and cholesteryl ester transfer protein cetp reduce hdl particle size in vitro dependence on the concentration of vldl. Circulation 82(4 Suppl 3): III282

Saxena, U.; Klein, M.G.; Goldberg, I.J. 1991: Lipoprotein lipase lpl increases lipoprotein retention by subendothelial cell matrix. Circulation 84(4 Suppl 2): II344

Goldberg, I.J.; Blaner, W.S.; Vanni, T.M.; Moukides, M.; Ramakrishnan, R. 1989: Lipoprotein lipase lpl regulation of high density lipoprotein hdl catabolism. Circulation 80(4 Suppl 2): II78

Rogers, M.P.; Zhao, X. 1996: Lipoprotein lipase mRNA levels in adipose tissue in lactation. Biochemical Society Transactions 24(2): 169s

Dugi, K.A.; Feuerstein, I.M.; Santamarina Fojo, S.; BrewerH.B.yan, J.; Hoeg, J.M. 1994: Lipoprotein lipase may contribute to the variant degree of atherosclerosis in homozygous familial hypercholesterolemia. Circulation 90(4 Part 2): I405

Saxena, U.; Kulkarni, N.M.; Ferguson, E.; Newton, R.S. 1993: Lipoprotein lipase mediated lipolysis of very low density lipoproteins increases monocyte adhesion to aortic endothelial cells. FASEB Journal 7(3-4): A793

Rumsey, S.C.; Obunike, J.C.; Arad, Y.; Deckelbaum, R.J.; Goldberg, I.J. 1992: Lipoprotein lipase mediated uptake and degradation of LDL by fibroblasts and macrophages. Circulation 86(4 Suppl 1): I155

Bessesen, D.H.; Etienne, J.; Goers, J.; Eckel, R.H. 1991: Lipoprotein lipase messenger rna and protein in the brain discrepancies in colocalization predict a novel regulation. Clinical Research 39(2): 330A

Yacoub, L.K.; Vanni, T.M.; Goldberg, I.J. 1990: Lipoprotein lipase messenger rna in neonatal and adult mouse tissues comparison of normal and combined lipase deficient cld mice assessed by in situ hybridization. Clinical Research 38(2): 396A

Mackay, A.G.; Rogers, M.P. 1989: Lipoprotein lipase messenger rna in rat tissues. Biochemical Society Transactions 17(1): 177

Williams, K.J.; Brocia, R.W.; Petrie, K.; Swenson, T.L. 1990: Lipoprotein lipase modulates net apolipoprotein b output by hepg2 cells. Circulation 82(4 Suppl 3): III283

Bendlova, B.; Vcelak, J.; Mazura, I.; Perusicova, J. 1997: Lipoprotein lipase mutation in Czech non-insulin dependent diabetes mellitus patients. Diabetologia 40(Suppl 1): A180

Wittrup, H.H.; Tybjaerg Hansen, A.; Nordestgaard, B.G. 1998: Lipoprotein lipase mutations and risk of ischemic heart disease A meta-analysis. Circulation 98(17): I791

Klannemark, M.; Suurinkeroinen, L.; Orho, M.; Groop, L.; Taskinen, M.R. 1998: Lipoprotein lipase polymorphism associated with increased plasma triglycerides in healthy subjects. Diabetologia 41(Suppl 1): A107

Shearer, G.C.; Newman, J.W. 2008: Lipoprotein lipase releases esterified oxylipins from very low-density lipoproteins. Prostaglandins Leukotrienes and Essential Fatty Acids 79(6): 215-222

Olivecrona, T.; Bengtsson Olivecrona, G.; Chajek Shaul, T.; Carpentier, Y.; Deckelbaum, R.; Hultin, M.; Peterson, J.; Patsch, J.; Vilaro, S. 1991: Lipoprotein lipase sites of synthesis and sites of action. Gotto, A M Jr And R Paoletti (Ed ) Atherosclerosis Reviews, Vol 22 Triglycerides: The Role in Diabetes And Atherosclerosis; International Symposium, Vienna, Austria, May 23-26, 1990 Xiii+232p Raven Press: New York, New York, Usa Illus 21-26

Wong, H.; Yang, D.; Hill, J.S.; Nikazy, J.; Schotz, M.C. 1997: Lipoprotein lipase subunit arrangement. FASEB Journal 11(9): A882

Cerami, A.; Kawakami, M. 1989: Lipoprotein lipase suppression by endotoxin induced mediator shock assay us patent 4822776 april 18 1989. Official Gazette of the United States Patent and Trademark Office Patents 1101(3): 1933

Fried, S.K.; Turkenkopf, I.; Goldberg, I.J.; Doolittle, M.H.; Ben Zeev, O.; Scholtz, M.C.; Greenwood, M.R.C. 1990: Lipoprotein lipase synthesis and degradation in adipocytes from lean and obese zucker rats. FASEB Journal 4(4): A917

Montalto, M.B.; Bensadoun, A. 1990: Lipoprotein lipase synthesis and secretion effects of concentration and type of fatty acids in adipocyte cell culture. Journal of Cell Biology 111(5 Part 2): 104A

Olivecrona, T.; Bengtsson Olivecrona, G. 1991: Lipoprotein lipase the molecule and its regulation. Weber, P C And A Leaf (Ed ) Atherosclerosis Reviews, Vol 23 Atherosclerosis: Its Pathogenesis And The Role Of Cholesterol; Second Bayer Ag International Workshop on Atherosclerosis, Faro, Portugal, November 27-December 2, 1990 Xi+288p Raven Press: New York, New York, Usa Illus 77-83

Karpe, F.; Frayn, K.N.; Humphreys, S.M.; Olivecrona, G.; Olivecrona, T. 1997: Lipoprotein lipase transport in plasma Role of muscle and adipose tissues in regulating plasma levels of lipoprotein lipase. Proceedings of the Nutrition Society 56(2): 202A

Talmud, P.J.; Hall, S.; Chu, G.; Ginsberg, H.N.; Ramakrishnan, R.; Miller, G.; Humphries, S.E. 1996: Lipoprotein lipase-93T/G transition is associated with lower plasma triglyceride levels and increases promoter activity in vitro. Circulation 94(8): I273

Eckel, R.H. 1993: Lipoprotein lipases and diabetes mellitus. Draznin, B, Eckel, R H Diabetes and atherosclerosis: Molecular basis and clinical aspects 77-102

Calandra, S. 1989: Lipoprotein lipases hepatic lipases and pancreatic lipases a family of lipolytic enzymes. Giornale della Arteriosclerosi 14(2): 51-52

Bradamante, S.; Barenghi, L. 1990: Lipoprotein lipid anomalies and lipid peroxidation in cancer patients. Free Radical Biology and Medicine 9(Suppl 1): 169

Ettinger, W.H.; Wahl, P.; Kuller, L.H.; Bush, T.L.; Tracy, R.; Manolio, T.A.; Borhani, N.O.; Wong, N.; O'leary D.H. 1991: Lipoprotein lipid levels in older people with cardiovascular disease. Circulation 84(4): II593

Kokkinos, P.F.; Hurley, B.F.; Smutok, M.A.; Farmer, C.; Reece, C.; Shulman, R.; Charabogos, C.; Patterson, J.; Goldberg, A.P. 1989: Lipoprotein lipid profiles and post heparin lipase activities are unaltered from strength training. Medicine and Science in Sports and Exercise 21(2 Suppl): S116

Busby, J.; Katzel, L.; Lumpkin, M.; Lakatta, L.; Goldberg, A. 1992: Lipoprotein lipids and postprandial lipemia in older athletes implication for the prevention of coronary artery disease in the elderly. Clinical Research 40(2): 394A

Busby, J.; Katzel, L.; Lumpkin, M.; Lakatta, L.; Goldberg, A. 1992: Lipoprotein lipids and postprandial lipemia in older athletes implications for the prevention of coronary artery disease in the elderly. Clinical Research 40(2): 394A

Kondo, K.; Itakura, H.; Koda, H.; Tanahashi, H.; Hosoda, K. 1997: Lipoprotein lowering agent, cholesterol lowering agent and medicaments comprising these agents respectively. Official Gazette of the United States Patent and Trademark Office Patents 1196(1): 408

Nomura, S.; Dong L M.; Sonobe, M.; Yamamura, T.; Yamamoto, A.; Haze, K.; Yamaguchi, T. 1990: Lipoprotein lp a as a risk factor of atherosclerosis. Japanese Circulation Journal 54(8): 1042

Widmann, M.D.; Sumpio, B.E. 1992: Lipoprotein lp a is a risk factor for peripheral vascular disease pvd the influence of coronary artery disease cad and diabetes dm. FASEB Journal 6(4): A1040

Boemi, M.; Ricciotti, R.; James, R.W.; Pometta, D.; Fumelli, P. 1991: Lipoprotein lpa in diabetic patients. Diabetologia 34(Suppl 2): A139

Jover Sanz, E.; Vella Ramirez, J.C. 1991: Lipoprotein lpa in serum and parental history of cardiovascular heart disease of young persons in castilla leon spain. European Heart Journal 12(ABSTR Suppl): 246

Schaefer, E.J.; Genest, J.J.; Jenner, J.L.; Mcnamara, J.R.; Silberman, S.; Usher, D.C.; Wilson, P.W.F.; Ordovas, J.M. 1990: Lipoprotein lpa levels in premature coronary artery disease patients. Clinical Chemistry 36(6): 957

Paillard, F.; Guillo, P.; Ruelland, A.; Kerbrat, M.; Druelles, P.; Cloarec, L.; Daubert, J.C. 1989: Lipoprotein lpa marker of coronary atherosclerosis. European Heart Journal 10(ABSTR Suppl): 314

Hoover Plow, J.; Challaplli, R.; Robinson, K.; Jacobsen, D. 1996: Lipoprotein lysine binding site function and hyperhomocysteinemia in patients with cardiovascular disease. Fibrinolysis 10(Suppl 3): 70

Brunzell, J.D.; Davidson, M.; Furberg, C.D.; Goldberg, R.B.; Howard, B.V.; Stein, J.H.; Witztum, J.L. 2008: Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care 31(4): 811-822

Levinson, S.S. 1997: Lipoprotein markers for coronary artery disease and where we are heading. Journal of Clinical Ligand Assay 20(1): 119-124

Fogelman A.M.; Berliner J.A.; Navab M.; Andalibi A.; Liao F.; Imes S.; Demer L.L.; Cushing S.D.; Kim J.; Et Al 1991: Lipoprotein mediated events in early atherogenesis. Journal of Cellular Biochemistry Suppl (15 Part C): 102

Schumaker, V.; Lembertas, A. 1992: Lipoprotein metabolism Chylomicrons, very-low-density lipoproteins and low-density lipoproteins. Lusis, A J , J I Rotter and R S Sparkes Monographs in Human Genetics, Vol 14 Molecular genetics of coronary artery disease: Candidate genes and processes in atherosclerosis xvii+453p S Karger AG: Basel, Switzerland; New York, New York, USA Illus Maps ISBN 3-8055-5558-X: 98-139

Karathanasis, S.K. 1992: Lipoprotein metabolism High-density lipoprotein. Lusis, A J , J I Rotter and R S Sparkes Monographs in Human Genetics, Vol 14 Molecular genetics of coronary artery disease: Candidate genes and processes in atherosclerosis xvii+453p S Karger AG: Basel, Switzerland; New York, New York, USA Illus Maps ISBN 3-8055-5558-X: 140-171

Kostner, G.M. 1991: Lipoprotein metabolism and atherogenesis: implications for therapy. Cardiology 78(3): 194-201

Breslow, J.L. 1994: Lipoprotein metabolism and atherosclerosis susceptibility in transgenic mice. Current Opinion in Lipidology 5(3): 175-184

Chipkin, S.R. 1994: Lipoprotein metabolism and coronary artery disease. Hurst, J W, Alpert, J S Diagnostic atlas of the heart 421-436

Ginsberg, H.N. 1994: Lipoprotein metabolism and its relationship to atherosclerosis. Medical Clinics of North America 78(1): 1-20

Yatsu, F.M.; Alam, R.; Ranganna, K.; Degraba, T.; Kraus, J. 1990: Lipoprotein metabolism and restriction fragment length polymorphisms for high density lipoprotein in strokes. Annals of Neurology 28(2): 225

Mitropoulos, K.A. 1994: Lipoprotein metabolism and thrombosis. Current Opinion in Lipidology 5(3): 227-235

Despres J P. 1991: Lipoprotein metabolism in abdominal obesity. Oomura, Y , Et Al (Ed ) Recent Advances in Obesity Research, Vol 6 Progress in Obesity Research, International Congress, Kobe, Japan, October 21-26, 1990 Xiii+688p John Libbey And Co Ltd : London, England, Uk; Paris, France Illus 285-290

Levy, E.; Lepage, G.; Bendayan, M.; Ronco, N.; Thibault, L.; Galeano, N.; Smith, L.; Roy, C.C. 1989: Lipoprotein metabolism in cystic fibrosis role of essential fatty acid deficiency. Gastroenterology 96(5 Part 2): A621

Howard, B.V. 1994: Lipoprotein metabolism in diabetes. Current Opinion in Lipidology 5(3): 216-220

Shepherd, J.; Packard, C.J. 1989: Lipoprotein metabolism in familial hypercholesterolemia. Arteriosclerosis 9(1 Suppl): I39-I42

Mazur, A.; Ayrault-Jarrier, M.; Chilliard, Y.; Rayssiguier, Y. 1992: Lipoprotein metabolism in fatty liver dairy cows. Diabete and Metabolisme 18(1 Part 2): 145-149

Sakai, N.; Hirano K I.; Yamashita, S.; Ueyama, Y.; Funahashi, T.; Nakamura, T.; Kihara, S.; Matsuzawa, Y.; Tarui, S. 1989: Lipoprotein metabolism in hyper alpha lipoproteinemia with deficiency of cholesteryl ester transfer protein. Japanese Circulation Journal 53(8): 903

Packard, C.J.; Shepherd, J. 1993: Lipoprotein metabolism in lipase deficient states: studies in primary and secondary hyperlipidaemia. Biochemical Society Transactions 21(2): 503-506

Angel, A. 1991: Lipoprotein metabolism in obesity. Sakamoto, N , A Angel And N Hotta (Ed ) International Congress Series, No 963 New Directions in Research And Clinical Works For Obesity And Diabetes Mellitus; Satellite Symposium Of The 6th International Congress Of Obesity: Obesity And Diabetes Mellitus, Nagoya, Japan, October 18-19, 1990 Xviii+411p Elsevier Science Publishers B V : Amsterdam, Netherlands; (Dist in The Usa And Canada By Elsevier Science Publishing Co , Inc : New York, New York, Usa) Illus 17-22

Warwick, G.L.; Packard, C.J. 1993: Lipoprotein metabolism in the nephrotic syndrome. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 8(5): 385-396

Pastores, G.M.; Berglund, L.; Desnick, R.J. 1996: Lipoprotein metabolism in type 1 Gaucher disease patients on enzyme therapy. Journal of Investigative Medicine 44(3): 225A

Chait, A.; Heinecke, J.W. 1994: Lipoprotein modification: cellular mechanisms. Current Opinion in Lipidology 5(5): 365-370

Chait, A. 1991: Lipoprotein modification an adjunct to plasma lipid and lipoprotein levels in the causation of atherosclerosis. Clinical Chemistry 37(6): 892-893

Steinberg, D. 1991: Lipoprotein modification and atherogenesis. Weber, P C And A Leaf (Ed ) Atherosclerosis Reviews, Vol 23 Atherosclerosis: Its Pathogenesis And The Role Of Cholesterol; Second Bayer Ag International Workshop on Atherosclerosis, Faro, Portugal, November 27-December 2, 1990 Xi+288p Raven Press: New York, New York, Usa Illus 115-121

Schlaich, M.P.; John, S.; Langenfeld, M.R.W.; Lackner, K.; Schmieder, R.E. 1997: Lipoprotein modulates basal but not stimulated NO-production and release. European Heart Journal 18(ABSTR Suppl ): 236

Bao, B.; Thomas, M.G.; Griffith, M.K.; Ryan, D.P.; Williams, G.L. 1994: Lipoprotein modulation of steroidogenesis, insulin-like growth factor-I production, and proliferation of luteal cells from bovine corpora lutea predicted to be normal or short-lived. Journal of Dairy Science 77(Suppl 1): 100

Bao, B.; Thomas, M.G.; Williams, G.L. 1994: Lipoprotein modulation of steroidogenesis, insulin-like growth factor-I production, and proliferation of small and concentrated large bovine luteal cells in vitro. Biology of Reproduction 50(Suppl 1): 85

Silva, E.L.; Chang, Y.H.; Moriel, P.; Miara, J.; Barbosa, D.S.; Araujo, F.B.; Abdalla, D.S.P. 1995: Lipoprotein oxidation Implications to atherogenesis. Ciencia e Cultura (Sao Paulo) 47(5-6): 376-384

Stocker, R. 1994: Lipoprotein oxidation: mechanistic aspects, methodological approaches and clinical relevance. Current Opinion in Lipidology 5(6): 422-433

Chirico, S.; Jay, M.T.; Mann, G.E.; Pearson, J.D.; Jacobs, M.; Bruckdorfer, K.R. 1996: Lipoprotein oxidation Release of NO from endothelial cells and the response to NO of target fibroblasts. Journal of Physiology (Cambridge) 491P: 33P

Gutteridge, J.M.; Swain, J. 1993: Lipoprotein oxidation: the 'fruit and vegetable gradient' and heart disease. British Journal of Biomedical Science 50(3): 284-288

Kaplan, I.V.; Hobbs, G.A.; Levinson, S.S. 1998: Lipoprotein oxidation and fibrinogen in coronary artery disease. Clinical Chemistry 44(6 Part 2): A76

Lusis, A.J.; Navab, M. 1993: Lipoprotein oxidation and gene expression in the artery wall. new opportunities for pharmacologic intervention in atherosclerosis. Biochemical Pharmacology 46(12): 2119-2126

Chisolm, G.M.; Irwin, K.C.; Penn, M.S. 1992: Lipoprotein oxidation and lipoprotein-induced cell injury in diabetes. Diabetes 41(Suppl 2): 61-66

Dempsey, R.J.; Lodder, R.A.; Davis, D.G.; Moore, R.W. 1995: Lipoprotein oxidation and symptomatic carotid artery atherosclerosis. Stroke 26(1): 170

Daugherty, A.; Roselaar, S.E. 1995: Lipoprotein oxidation as a mediator of atherogenesis: insights from pharmacological studies. Cardiovascular Research 29(3): 297-311

Tribble, D.L. 1995: Lipoprotein oxidation in dyslipidemia: insights into general mechanisms affecting lipoprotein oxidative behavior. Current Opinion in Lipidology 6(4): 196-208

Hsia, J.; Otvos, J.D.; Rossouw, J.E.; Wu, L.; Wassertheil-Smoller, S.; Hendrix, S.L.; Robinson, J.G.; Lund, B.; Kuller, L.H. 2008: Lipoprotein particle concentrations may explain the absence of coronary protection in the women's health initiative hormone trials. Arteriosclerosis Thrombosis and Vascular Biology 28(9): 1666-1671

Fruchart J C. 1991: Lipoprotein particles an improved pathophysiological approach to diagnosis and treatment of dyslipoproteinemias. Clinical Chemistry 37(6): 893

Fruchart, J.C. 1991: Lipoprotein particles clinical significance. Vanhoutte, P M And P Douste-Blazy (Ed ) Fish Oil And Blood-Vessel Wall Interactions; International Symposium, Granada, Spain, February 23-25, 1990 Viii+163p John Libbey And Co Ltd : London, England, Uk Illus Paper 117-128

Koren, E.; Wilson, P.; Corder, C.; Alaupovic, P. 1989: Lipoprotein particles in patients with coronary artery disease. FASEB Journal 3(4): A1218

Cambien, F.; Parra, H.J.; Arveiler, D.; Cambou, J.P.; Evans, A.; Bingham, A.; Douste Blazy, P.; Ducimetiere, P.; Fruchart, J.C. 1990: Lipoprotein particles in patients with myocardial infarction and controls. Circulation 82(4 Suppl 3): III348

Brunzell, J.D.; Chait, A. 1990: Lipoprotein pathophysiology and treatment. Rifkin, H And D Porte, Jr (Ed ) Ellenberg And Rifkin's Diabetes Mellitus: Theory And Practice, Fourth Edition Xvi+972p Elsevier Science Publishing Co , Inc : New York, New York, Usa; Amsterdam, Netherlands Illus 756-767

Claesson, K.; Mayer, A.D.; Squifflet, J.P.; Grabensee, B.; Eigler, F.W.; Behrend, M.; Vanrenterghem, Y.; van Hooff, J.; Morales, J.M.; Johnson, R.W.; Buchholz, B.; Land, W.; Forsythe, J.L.; Neumayer, H.H.; Ericzon, B.G.; Mühlbacher, F. 1998: Lipoprotein patterns in renal transplant patients: a comparison between FK 506 and cyclosporine a patients. Transplantation Proceedings 30(4): 1292-1294

Burns, G.; Engel, W D.; Seidel, C. 1996: Lipoprotein peptides and their use. Official Gazette of the United States Patent and Trademark Office Patents 1182(4): 2507

Tsai, Y.H.; Park, S.; Snook, J.T. 1997: Lipoprotein phenotype and lipoprotein metabolism in subjects fed different dietary fats. FASEB Journal 11(3): A166

Skopal, J.; Karadi, I.; Bori, Z.; Vastag, M.; Toth, M.; Romics, L.; Nagy, Z. 1998: Lipoprotein phenotypes display differences in the expression of PAI-1 mRNA in human brain microvessel endothelial cells. Fibrinolysis and Proteolysis 12(Suppl 1): 96

Brown, L.D.; Azrolan, N.; Thomas, L.L.; Zhao, Z.H.; Friedman, E.A. 1993: Lipoprotein phenotypes in patients with unremitting nephrotic syndrome. Journal of the American Society of Nephrology 4(3): 271

Ginsberg, H.N. 1998: Lipoprotein physiology. Endocrinology and Metabolism Clinics of North America 27(3): 503-519

Ginsberg, H.N. 1990: Lipoprotein physiology and its relationship to atherogenesis. Endocrinology and Metabolism Clinics of North America 19(2): 211-228

Marcovina, S.M.; Williams, M.A.; King, I.B.; Sorensen, T.K.; Zingheim, R.W.; Luthy, D.A. 1998: Lipoprotein plasma levels in preeclamptic and normotensive pregnant women. American Journal of Obstetrics and Gynecology 178(1 Part 2): S114

Dardik, B.N.; Chatelain, R.E.; Schwartzkopf, C.D.; Steele, R.E. 1994: Lipoprotein production by HEPG2 cells and its regulation by cytokines. FASEB Journal 8(4-5): A454

Christiansen, L.B.; Mustafa, T.; Korsgaard, B. 1998: Lipoprotein profile and prevalence of coronary lesions in estradiol-treated rainbow trout. Vaudry, H, Tonon, M -C, Roubos, E W, de Loof, A Annals of the New York Academy of Sciences; Trends in comparative endocrinology and neurobiology: From molecular to integrative biology 460-462

Dziewulska-Bokiniec, A.; Wojtacki, J.; Skokowski, J.; Wróblewska, M. 1994: Lipoprotein profile in breast cancer women: effect of tamoxifen treatment. Neoplasma 41(6): 337-340

Stamogiannou, L.; Vlachopapadopoulou, E.; Giannacouli, M.; Polichroni, I.; Papadopoulou, A.; Maropoulos, G.; Bartsocas, C.S. 1998: Lipoprotein profile in growth hormone deficient children and its change with treatment. Hormone Research (Basel) 50(Suppl 3): 147

Dallmeijer, A.J.; Hopman, M.T.E.; Van Der Woude, L.H.V. 1996: Lipoprotein profile in physically active and sedentary persons with tetraplegia. Medicine and Science in Sports and Exercise 28(5 Suppl): S108

Granot, E. 1996: Lipoprotein profile in post-liver transplant children Hypertriglyceridemia and a decrease in HDL-3/HDL-2 ratio. Journal of Hepatology 25(Suppl 1): 127

Janssen, T.W.J.; Hollander, A.P.; Van Der Woude, L.H.V. 1995: Lipoprotein profile, aerobic power, and physical activity in men with spinal cord injuries. Medicine and Science in Sports and Exercise 27(5 Suppl): S208

Aranow, C.; Enoch, L.; Barland, P. 1990: Lipoprotein profiles and corticosteroid treatment in systemic lupus erythematosus. Arthritis and Rheumatism 33(9 Suppl): S12

Colyvas, N.; Phillips, N.R.; Stoney, R.J.; Havel, R.J.; Rapp, J.H. 1989: Lipoprotein profiles of patients with recurrent carotid stenosis. Surgical Forum 40: 281-283

Vijayagopal, P.; Srinivasan, S.R.; Radhakrishnamurthy, B.; Berenson, G.S. 1991: Lipoprotein proteoglycan complexes from atherosclerotic lesions promote cholesteryl ester accumulation in human monocyte macrophages. Clinical Research 39(4): 799A

Walli, A.K.; Groene, H.J.; Siegele, B.; Strauss, T.; Groene, E.F.; Fraunberger, P.; Seidel, D. 1993: Lipoprotein receptor activity in renal cell carcinoma in humans as related to hypocholesterolemia. Journal of the American Society of Nephrology 4(3): 327

Schneider, W.J.; Nimpf, J. 1993: Lipoprotein receptors Old relatives and new arrivals. Current Opinion in Lipidology 4(3): 205-209

Van Berkel, T.J.; Ziere, G.J.; Bijsterbosch, M.K.; Kuiper, J. 1994: Lipoprotein receptors and atherogenic receptor-mediated mechanisms. Current Opinion in Lipidology 5(5): 331-338

Tóth, I.E. 1992: Lipoprotein receptors and steroidogenesis in adrenocortical cells. Journal of Steroid Biochemistry and Molecular Biology 43(5): 395-402

Goldstein, J.L.; Brown, M.S. 1992: Lipoprotein receptors and the control of plasma LDL cholesterol levels. European Heart Journal 13 Suppl B: 34-36

Daugherty, A. 1994: Lipoprotein receptors in arterial tissue: relation to the pathology of atherosclerosis. Coronary Artery Disease 5(3): 211-215

Schneider, W.J. 1992: Lipoprotein receptors in oocyte growth. Clinical Investigator 70(5): 385-390

Jenkinson, H.F.; McNab, R.; Loach, D.M.; Tannock, G.W. 1995: Lipoprotein receptors in oral streptococci. Developments in Biological Standardization 85: 333-341

Goldstein, J.L.; Brown, M.S. 1989: Lipoprotein receptors molecular machines that lower blood cholesterol. Abstracts of Papers American Chemical Society 197: BIOL 27

Brown, M.S.; Goldstein, J.L. 1990: Lipoprotein receptors: therapeutic implications. Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 8(1): S33

Teruel, J.L.; Lasuncion, M.A.; Tato, A.; Tenorio, T.; Rivera, M.E.; Aguilera, A.; Marcen, R.; Ortuno, J. 1996: Lipoprotein reduction in dialysis patients after androgen therapy. Journal of the American Society of Nephrology 7(9): 1466

Zhang, H.; Niesel, D.W.; Peterson, J.W.; Klimpel, G.R. 1998: Lipoprotein release by bacteria: potential factor in bacterial pathogenesis. Infection and Immunity 66(11): 5196-5201

Mcnamara, J.R.; Shah, P.K.; Nelson, S.M.; Nakajima, K.; Wilson, P.W.F.; Schaefer, E.J. 1996: Lipoprotein remnant cholesterol and triglyceride values in coronary cases and Framingham controls. Circulation 94(8): I94

Hennig, B.; Watkins, B.A.; Chung, B.H.; Alvarado, A. 1991: Lipoprotein remnant mediated changes in endothelial barrier function in culture are related to lipoprotein fatty acid compositional changes. FASEB Journal 5(5): A1253

Naruszewicz M.; De Langavant G.C.; Davignon I.; Giroux L.M.; Davignon J. 1992: Lipoprotein resistance to oxidation in a hypercholesterolemic patient with high lpa levels and carotenemia. Clinical and Investigative Medicine 15(4 Suppl): A9

Oganov, R.; Kisseleva, N.; Perova, N.; Olferjev, A.; Schelzina, N. 1997: Lipoprotein response to Endur-Acin treatment in hypercholesterolaemic patients with different levels of lipoprotein. Cardiovascular Drugs and Therapy 11(Suppl 2): 408

Nestel, P.J.; Clifton, P.M.; Noakes, M. 1993: Lipoprotein response to diet is related to body fat distribution. FASEB Journal 7(3-4): A413

Hughes, V.; Fiatarone, M.; Charnley, J.; Ferrara, C.; Mcnamara, J.; Schaefer, E.; Evans, W. 1992: Lipoprotein response to exercise training and a high carbohydrate high fiber diet in glucose intolerant subjects. FASEB Journal 6(4): A1214

Dreon, M.; Krauss, R.M. 1992: Lipoprotein response to low-fat diets in women is related to parental low density lipoprotein subclass phenotypes. Circulation 86(4 Suppl 1): I405

Schmeisser, D.; Bowen, P.E.; Prewitt, T.E.; Cole, T.A. 1992: Lipoprotein responses of premenopausal women switched from 37 percent fat to 21 percent fat diets containing similar fatty acid composition. FASEB Journal 6(4): A1081

Bowen, P.E.; Schmeisser, D.; Prewitt, T.E.; Cole, T.A. 1991: Lipoprotein responses to a moderate fat high fiber diet in premenopausal women. Clinical Research 39(2): 642A

Hoang, V.Q.; Suckling, K.E.; Botham, K.M. 1992: Lipoprotein secretion by cultured hamster hepatocytes. Biochemical Society Transactions 20(4): 337s

Fagan, A.M.; Holtzman, D.M.; Sun, Y.; Wu, S.; Mathur, T.; Getz, G.S.; Reardon, C.A.; Lukens, J.; Shah, J.A.; Ladu, M.J. 1998: Lipoprotein secretion by primary astrocytes from wild type, apoE null and human apoE transgenic mice. Society for Neuroscience Abstracts 24(1-2): 1712

Mackness, M.I.; Durrington, P.N. 1992: Lipoprotein separation and analysis for clinical studies. Converse, C A And E R Skinner (Ed ) Practical Approach Series: Lipoprotein Analysis Xx+251p Irl Press at Oxford University Press: Oxford, England, Uk; New York, New York, Usa Illus 1-42

Yee, M.S.; Pavitt, D.V.; Tan, T.; Venkatesan, S.; Godsland, I.F.; Richmond, W.; Johnston, D.G. 2008: Lipoprotein separation in a novel iodixanol density gradient, for composition, density, and phenotype analysis. Journal of Lipid Research 49(6): 1364-1371

Joles, J.A.; Willekes Koolschijn, N.; Rabelink, A.J.; Erkelens, D.W. 1989: Lipoprotein spectrum and the effect of hydroxy methylglutaryl coenzyme a reductase inhibition in nagase analbuminemic rats. European Journal of Clinical Investigation 19(2 Part 2): A46

Ramaswamy, C.; Steadman, R.; Jordan, N.; Westwick, J.; Williams, J.D. 1995: Lipoprotein stimulates leukocyte adherence to endothelial cells in vitro. Journal of the American Society of Nephrology 6(3): 908

Mondorf, U.F.; Olbrich, H.G.; Siekmeier, R.; Oppermann, E.; Bender, M.; Maerz, W.; Scheuermann, E.; Gross, W. 1995: Lipoprotein stimulates proliferation of human mesangial cells in culture by a tyrosine kinase dependent pathway and increases intracellular free calcium. Journal of the American Society of Nephrology 6(3): 803

Davis, R.A. 1991: Lipoprotein structure and secretion. Vance, D E, Vance, J New Comprehensive Biochemistry; Biochemistry of lipids, lipoproteins and membranes: 403-426

Patsch, J.R. 1998: Lipoprotein structure in type II diabetes. Belfiore, F, Lorenzi, M, Molinatti, G M, Porta, M Frontiers in Diabetes; Molecular and cell biology of type 2 diabetes and its complications 97-104

Moinat, M.; Borghini, I.; Giacobino, J.P.; Pometta, D.; James, R.W. 1989: Lipoprotein subfractions modulate acyl coenzyme cholesterol transferase acat activity in the macrophage ic 21 cell line. Experientia 45(ABSTR): A61

Murray, K.; Nair, M.P.; Pritchard, P.H.; Lacko, A.G. 1998: Lipoprotein substrate binding site of LCAT. FASEB Journal 12(8): A1381

Hayashi, S.; Yu, F.G.ng 1993: Lipoprotein synthesis and secretion by cultured eel hepatocytes. Comparative Biochemistry and Physiology B Comparative Biochemistry 105(3-4): 443-448

Santamarina Fojo, S. 1991: Lipoprotein transport and metabolism. Journal of Cellular Biochemistry Suppl (15 Part B): 10

Breslow, J.L. 1991: Lipoprotein transport gene abnormalities underlying coronary heart disease susceptibility. Annual Review of Medicine 42: 357-371

Bierer, T.L.; Merchen, N.R.; Nelson, D.R.; Erdman, J.W.Jr 1993: Lipoprotein transport of carotenoids in the preruminant calf. FASEB Journal 7(3-4): A521

Moll, G.W.Jr.; Liu, G.C.; Lin, G.L. 1995: Lipoprotein transport of dehydroepiandrosterone in plasma under physiologic conditions. Journal of Investigative Medicine 43(Suppl 1): 70A

Gaw, A.; Packard, C.J.; Shepherd, J. 1992: Lipoprotein turnover and metabolism. Converse, C A And E R Skinner (Ed ) Practical Approach Series: Lipoprotein Analysis Xx+251p Irl Press at Oxford University Press: Oxford, England, Uk; New York, New York, Usa Illus 119-144

Crawford, K.C.; Mobley, W.C. 1998: Lipoprotein uptake is necessary for trafficking of growth factor receptors to the plasma membrane. Society for Neuroscience Abstracts 24(1-2): 1783

Cortella, A.; Zambon, S.; Manzato, E. 1993: Lipoprotein variations after acute myocardial infarction. Giornale della Arteriosclerosi 18(1): 1-3

Hughes, S.D.; Ighani, S.; Verstuyft, J.; Rubin, E.M. 1996: Lipoprotein vascular binding In vivo analysis of the role of lysine binding sites using adenovirus mediated gene transfer. Circulation 94(8): I38

Gault, M.; Longerich, L.; Prabhakaran, V. 1994: Lipoprotein with CAPD, hemodialysis and transplantation. Journal of the American Society of Nephrology 5(3): 491

Carlander, B. 1963: Lipoprotein, lipoprotein lipase and Atromid fandrosterone and chlorophenoxyisobutyric acid ester. J Atherosclerosis Res: 509-517

Michaels, J.R.; Atkinson, J.D.; Lardinois, C.K.; Starich, G.H. 1993: Lipoprotein- , triglyceride, and cholesterol levels in a neonatal population. Clinical Research 41(1): 6A

Moxey Mims, M.M.; Eberhard, G.; Gingell, R.; Feld, L.G. 1993: Lipoprotein-A levels in pediatric dialysis and renal transplant patients. Pediatric Research 33(4 Part 2): 362A

Lerman, A.; McConnell, J.P. 2008: Lipoprotein-associated phospholipase A2: a risk marker or a risk factor?. American Journal of Cardiology 101(12a): 11f-22f

Anderson, J.L. 2008: Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention. American Journal of Cardiology 101(12a): 23f-33f